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ABBREVIATIONS 
 
 MS Multiple Sclerosis  
 MRI Magnetic Resonance Imaging 
 MR Magnetic Resonance 
 GM Gray matter 
 WM total White matter 
 aWM abnormal White matter 
 CSF Cerebrospinal Fluid 
 fGM fractional Gray matter (GM/ICV) 
 fWM total fractional White matter (WM/ICV) 
 faWM fractional abnormal White matter (aWM/ICV) 
 fCSF fractional Cerebrospinal Fluid (CSF/ICV) 
 ICV Intracranial volume 
 LL Lesion Load 
 RR Relapsing Remitting 
 PP Primary Progressive 
 SP Secondary Progressive  
 PD, N(H) Proton Density 
 TE echo time 
 TR repetition time 
 QMCI Quantitative Magnetic Color Imaging 
 ROI Region of Interest 
 PAWM Potentially abnormal WM 
 PL potential lesions 
 VBM Voxel-Based Morphometry 
 EDSS Expanded Disability Status Scale 
 DD Disease Duration 
 CI Confidence Interval 
 FWHM Full Width at Half Maximum 
 3 
INDEX 
 
INTRODUCTION…………………………………………………. pag. 6 
 
QUANTIFICATION OF BRAIN TISSUE VOLUMES  
WITH MRI: SEGMENTATION TECHNIQUES……………….. pag. 8 
 MR data characteristics………………………………………….. pag. 9 
  1. Noise……………………………………………………… pag. 10 
  2. Partial Volume Effect…………………………………….. pag. 10 
  3. Intensity Inhomogeneity………………………………….. pag. 10 
  4. Motion…………………………………………………….. pag. 11 
 Segmentation methods…………………………………………... pag. 11 
  1. Automatic Thresholding………………………………….. pag.12 
  2. Region Growing…………………………………………... pag.13 
  3. Matching to a normalized template (atlas)………………... pag.14 
  4. Edge detection…………………………………………….. pag.15 
  5. Active contour models……………………………………. pag.16 
  6. Multiparametric methods…………………………………. pag.17 
 
A MULTIPARAMETRICAL FULLY AUTOMATED  
SEGMENTATION METHOD FOR MS………………………….. pag. 20 
 Generation of the multiparametric maps………………………… pag. 20 
 Segmentation procedure…………………………………………. pag. 23 
  1. Calculation of GM/WM R1 cutoff………………………... pag. 25 
 MS plaques automatic segmentation……………………………. pag. 27 
  1. Identification of WM lesions…………………………….. pag. 28 
  1.1 Identification of “potential lesions”………………… pag. 31 
  1.2 Fragmentation od spatial clusters…………………… pag. 31 
  1.3 Lesion classification………………………………… pag. 31 
 Validation……………………………………………………….. pag. 33 
  1. Specificity of the method………………………………… pag. 36 
  2. Sensitivity of the method………………………………… pag. 36 
 4 
  3. A posteriori correction of GM and WM volumes………… pag. 37 
 
BRAIN TISSUE VOLUMES IN MS: PREVIOUS RESULTS….. pag. 38 
 
AIM OF THE WORK……………………………………………… pag. 40 
 
FIRST AIM: OPTIMIZATION OF MULTIPARAMETRIC  
SEGMENTATION FOR MS……………………………………… pag. 42 
 Calculation of GM/WM R1 cutoff with multigaussian fittine…… pag. 42  
 Validation of multigaussian fitting in MS simulated studies…….. pag. 45 
 
SECOND AIM: QUANTIFICATION OF GLOBAL  
BRAIN TISSUE VOLUMES IN A LARGE  
POPULATION OF MS PATIENTS………………………………. pag. 47 
 Patient recruitment………………………………………………. pag. 47 
 MRI studies……………………………………………………… pag. 49 
 Results of the segmentation of a large population  
 of MS patients…………………………………………………… pag. 50 
 
THIRD AIM: REGIONAL ANALYSIS OF GRAY AND  
WHITE MATTER LOSS IN RELAPSING-REMITTING  
MULTIPLE SCLEROSIS………………………………………… pag. 54 
 Subjects…………………………………………………………. pag. 54 
 MRI studies………………………………………………………. pag. 55 
 Optimized VBM………………………………………………… pag. 55 
 Statistical analysis………………………………………………. pag. 59 
 Analysis of brain asymmetry……………………………………. pag. 61 
 Results…………………………………………………………... pag. 62 
 
DISCUSSION……………………………………………………… pag. 70 
 Methodological Issues: segmentation……………………………. pag. 70 
 Methological Issues: VBM………………………………………. pag. 72 
 5 
 Global tissue volumes……………………………………………. pag. 72 
 Regional findings: GM………………………………………… pag. 76 
 Regional findings: WM………………………………………… pag. 81 
 
CONCLUSIONS…………………………………………………… pag. 83 
 
BIBLIOGRAPHY………………………………………………… pag. 85 
 6 
INTRODUCTION 
 
Multiple sclerosis (MS) is the most common neurological disease of young adults, 
and despite the fact that the disease was described over 130 years ago, 
understanding of pathogenesis remain elusive. The histopathologic features of MS 
include multiple foci of inflammation and demyelination as well as potentially 
substantial destructive or degenerative changes in both white matter (WM) and 
gray matter (GM) (Cifelli, 2002; Kidd, 1999; Peterson, 2001; Trapp, 1998). In the 
last 15 years, Magnetic Resonance Imaging (MRI) has assumed an important role 
as a tool to assist in the diagnosis of multiple sclerosis and to monitor the 
evolving disease in vivo. MRI allows to identify with high specificity white matter 
lesions, providing a sensitive measure of the evolving pathology, which is often 
not clinically apparent.  
Abnormalities have been reported also in the so-called normal appearing white 
matter and cortex using quantitative magnetic resonance methods, and 
pathological studies have confirmed the presence of disease in these regions. 
Furthermore, MRI data have led to the hypothesis that progression of the disease, 
up to a stage of no return, is dependent on the cumulative effect of axonal damage 
(De Stefano, 2001), which may ultimately result in MRI-visible brain atrophy 
(Miller, 2002).  
Tissue damage in MS is in fact not limited to the white matter (WM) as from 
inflammation axonal transection ensues (Ferguson, 1997; Trapp, 1998), and this 
process may extend by Wallerian degeneration, indirectly demonstrated by N-
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acetylaspartate reduction in MR spectroscopy studies (Davie, 1995; Davie, 1994; 
Rooney, 1997), possibly contributing to gray matter (GM) loss.  
Progression of brain atrophy, above normal age-related brain volume changes, has 
been detected in MS using linear measures of width of the ventricles and/or 
volumetric measures of the brain/intracranial volume (ICV) ratio (Adams and 
Koziol, 2000; Losseff, 1996; Rudick, 1999; Simon, 1999), over a period of time 
as short as 1 year. These findings raised the hypothesis that neurodegenerative 
pathology in MS may represent a major part in the development of permanent 
disability. Moreover the accumulation of damage to the nervous system may play 
a different role in the different clinical types of MS: relapsing-remitting (RR), 
primary progressive (PP), secondary progressive (SP). 
Consequently, there has been a growing interest on the possibilities offered by 
MRI to measure structural changes in the brain of MS patients, particularly 
regarding techniques which provide quantitative estimates of brain tissue 
volumes. 
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QUANTIFICATION OF BRAIN TISSUE VOLUMES WITH 
MRI: SEGMENTATION TECHNIQUES 
 
There has been an active search for sensitive MRI methods to measure brain 
atrophy and other objective parameters of tissue damage. In an effort to obtain 
reliable, reproducible, and objective measurements of brain atrophy, MRI 
methods have evolved from semiautomated, operator-dependent segmentation 
techniques to automated, operator-independent ones (Miller, 2002; Pelletier, 
2004). 
 
Quantification of brain tissue volumes involves the identification of each 
intracranial tissue, including GM, WM, CSF.  Such object-based processes may 
involve some or all of the following: detecting the presence of the tissues, 
localizing their boundary or the position of their centre, measuring their size, 
characterizing their shape and identifying their anatomical name or pathological 
type.   
These processes all depend on the fundamental underlying process of 
segmentation, that in a more general sense can be defined as the partitioning of 
the image into objects. Segmentation methods need to be reproducible, accurate 
and efficient. 
Segmenting a brain to divide it into regions  usually involves examining every 
voxel in the image and assigning it a label that associates it with a tissue.  The 
assignment can be based on properties of that voxel, properties of its neighbours, 
and/or similarity to other voxels which are already assigned to a region.  
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In medical images of the brain, the regions are usually referred to by experts with 
anatomical names for specific objects (such as “thalamus”) or with a names for a 
type of tissue, vis. gray matter (GM), white matter (WM), or cerebrospinal fluid 
(CSF). Structures are mainly recognized from their morphology and spatial 
relationships.  Many of the individual structures are composed of one class of 
tissue.  Various parameters of the segmented structures can be calculated, and 
compared with normal structures or previous measurements performed using the 
same technique. MR image segmentation allows the visualization of the 
individual anatomical structures in 3D, providing an aid to surgery and treatment 
planning, as well as a means for studying the effect of the locality of abnormal 
tissues in disease. 
 
In general, segmentation and labelling of MR images is a very difficult and time-
consuming process (Farmer, 1996; Kapur, 1995). Often there is not enough 
information in the image to segment a complete structure.  Low quality of data 
and having irregular shape which is difficult to represent mathematically makes 
MR segmentation more difficult. 
 
MR data characteristics 
Before focusing on segmentation techniques, it is worth to take a look to some 
characteristic of MR data that affect image segmentation: noise, partial volume 
effect, radio-frequency inhomogeneities and motion. 
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1. Noise 
The signal to noise ratio can be relatively low for poor quality MR images. The 
commonly used techniques for image noise reduction involve some form of 
smoothing.  Smoothing modifies each pixel intensity according to the intensities 
of its spatial neighbors. While reducing the noise, these techniques also reduce the 
image contrast.  There are also other noise reduction techniques that make a priori 
assumptions about the statistical nature of the noise.  Noise is a frequent problem 
in any image acquisition process, including MRI.  In many cases segmentation 
techniques are evaluated on their relative sensitivity to noise. 
 
2.  Partial Volume Effect  
MR images have limited spatial resolution, thus, each voxel can be occupied by 
more than one tissue type; its intensity can be the average of the intensity from all 
component tissues, which blurs the intensity distinction between tissue classes at 
the boundary of the objects.  This effect blurs many of the tissue boundaries of an 
MR image, making tissue boundary detection difficult (Laidlaw, 1998). 
Furthermore MR images are usually acquired as a sequence of 2D slices, which 
are then stacked to form the image of a volume.  In-plane spatial resolution is 
typically higher than the slice thickness, leading to voxels which have cuboidal 
shape rather than cubic.  This anisotropic sampling can cause problems for certain 
types of segmentation algorithm. 
 
3. Intensity Inhomogeneity 
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MR images are subject to artefactual variation in signal intensity across the field 
of view. The main causes are inhomogeneity of the radio-frequency field resulting 
in non-linear gain artifact in the images.  This is problematic for brain 
segmentation algorithms that assume that voxels containing a particular tissue 
type have similar intensities throughout the MR volume.  The artefactual intensity 
variation perturbs the intensity distributions, increasing overlap and leading to 
substantial misclassification when methods based only on intensity are used.  
Methods to compensate for intensity inhomogeneity are thus important to improve 
the results of many segmentation algorithms. 
 
4. Motion  
Patient movement during the scan causes artefacts. Because signal acquisition 
occurs in the frequency domain, artefacts in the image space tend to have a 
complex appearance and are hard to correct by post-processing. The problem is 
more acute when multimodal datasets are acquired because the duration of image 
acquisition is usually longer. 
 
Segmentation methods 
Separating brain tissues can be done basically in two ways: based on the 
homogeneity of a region with the so-called region based methods, or if 
homogeneity is poor but contrast between regions is high with the so-called 
boundary based methods.  
 12 
Region based techniques rely on the homogeneity of spatially localized features, 
whereas boundary based techniques attempt to identify the locations of significant 
changes in grey level, using discontinuity measures.   
Apart from the calculation algorithm used, another important characteristic of the 
segmentation methods is their operator dependence that goes from manual 
parcellation through semi-automated to completely automatic operator 
independent ones. 
 
1. Automatic  thresholding 
Thresholding is the simplest region-based method, where the similarity criterion is 
set by the threshold.  It is one of the most commonly use image segmentation 
processes.   
The automatic thresholding techniques usually involve four basic steps:  
1) A histogram of the MRI voxel intensities is produced 
2) A threshold is selected based on the fact that most of the relatively high 
intensity voxels in the MR image belong to the brain 
3) The threshold is then applied to the image to produce a binary mask 
4) Some kind of morphology and/or expert knowledge is applied to the 
binary mask to remove non-brain regions. The resulting mask identifies 
the brain and thus, the intracranial boundary.  
This procedure is usually applied to the histogram of the whole image (global 
thresholding), but can be performed also locally on any sub-region.   
Some authors use iterative thresholding to distinguish brain tissues from others in 
axial MR slices by means of an adaptive technique, that iteratively adjust the 
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initial threshold on the basis of the geometry of resulting masks (i.e. the head 
mask includes the brain mask) (Suzuki and Toriwaki, 1991). This method is 
ineffective in the presence of RF inhomogeneity and in slices where the brain is 
not one homogeneous region closely surrounded by the skull (e.g. in the 
lowermost slices where cerebellum and temporal tips are separated). 
 
Automatic thresholding (Atkins and Mackiewich, 1998; Brummer, 1993) is often 
used to perform a crude segmentation of the brain.  Refinement of the brain 
contour is then performed using several approaches, including discontinuity-based 
morphological processing (Atkins and Mackiewich, 1998), active contour and 
deformable models (Kaus, 2003; Vaillant and Davatzikos, 1997), and other 
techniques (Chakraborty, 1994; Holden, 1995).   
 
2. Region growing  
Region growing methods require the identification of a seed point to start 
classification of voxel intensity and absorb neighbouring points satisfying a 
homogeneity measure to expand the region. For this region they are in general 
semi_automatic method.  
The homogeneity measure is computed based on some statistics from region 
and/or its local neighbourhood.  Pannizzo et al. (Pannizzo, 1992) consider the 
grey level change along horizontal line outward from the centre of the image 
(brain) to detect intracranial boundary.  They use an adaptive threshold to detect 
the first significant change in the intensity.  A running average of voxels along the 
line is used to refine the boundary.   
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Zijdenbos et al. (Zijdenbos, 1994) fitted a surface to the voxels initially labelled as 
a boundary.  They then calculated a new threshold and refined the boundary 
position by applying this threshold.  
 
Hojjatoleslami et al. (Hojjatoleslami and Kruggel, 2001) developed a region 
growing algorithm which starts from a high grey level point inside the white 
matter, absorbs the highest grey level point in its boundary to expand the region.  
A discontinuity measure, so called peripheral contrast, is employed to choose the 
boundary for the region. Peripheral contrast computes the difference between 
average grey level of internal boundary and the external boundary during the 
growing process.  It computes a global measure of discontinuity for the boundary 
of the region which is robust in the presence of noise.  The algorithm is used in 
two steps; in the first step, a starting point inside the scalp is used to segment the 
scalp and eyes, in the second step the algorithm starts from a seed point inside the 
white matter to segment brain tissues (WM, GM and CSF).  These two starting 
points are the only interactive settings used.  
 
3. Matching to a normalized template (atlas) 
Atlases have been used as a reference for segmentation of 3D MR images by 
some researchers. This is accomplished by first registering an atlas volume with 
the subject volume and then using the atlas to segment the mapped structures from 
the test image. The initial segmentation is then normally refined using various 
local properties (Dawant, 1999; Hartmann, 1999; Van Leemput, 2001ì). 
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Many different algorithms for registering the 3D atlas onto the MR volume have 
been used. An example is described by Hartmann (Hartmann, 1999) who used a 
two-step registration.   
 
4. Edge detection 
Edge detection methods rely on changes in the grey level, rather than their actual 
values, to produce closed boundary contours.  Edges can be detected using a 
variety of operators including Sobel, Laplace, Perwitt or Canny operators 
(Mohamed, 1999).  Prior smoothing with a Gaussian function, is often used.  
These operators are generally a type of gradient magnitude transform, the result of 
which is then thresholded to produce a large number of disconnected edge 
segments.  The disadvantages include the loss of edge detail in certain parts of the 
image, where magnitude of the edge strength is lower than the global threshold; 
and the fact that the edge segments are disconnected and must be linked to each 
other before any objects are extracted.  
 
Among Edge-detection method watershed algorithms are commonly applied to a 
gradient magnitude image, to divide the image into the small regions with closed 
boundaries, surrounding a single local minimum of magnitude.  Letterboer  et al. 
(Letteboer, 2004) applied the watershed method to anisotropically filtered MR 
images.  They evaluated a range of such operators for the purpose of interactive 
multi-scale segmentation of grey and white matter in T1 weighted 2D MR images.  
Along the watershed boundaries, the gradient magnitude is locally maximal in the 
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direction orthogonal to the edge.  The main disadvantage is that when the level of 
noise is high, a large number of small regions is generated.  It is almost always 
necessary to simplify the watershed segmentation by merging locally similar 
regions.  
 
5. Active Contour models 
Deformable models have been a popular technique for segmentation of medical 
data, in part because of their ability to incorporate approximate shape constraints. 
In 3D systems that use such models typically represent anatomical structures 
using stacks of deformable contours in 2D or may use a true 3D deformable 
surfaces.  Example systems include Chakraborty’s Fourier snakes (Chakraborty, 
1994). 
Atkins (Atkins and Mackiewich, 1998) used an active contour model to refine the 
boundary between the brain and intracranial cavity.  They use a four-term energy 
function including curvature (to force the contour towards a circular shape), 
balloon (to push the contour outward to cover a larger region) intensity (to drive 
the contour toward low intensity area) and gradient (to force the contour toward 
strong gradient points).  The weighted sum of the energy functions is computed 
and every boundary point is moved to the point of minimum energy in its local 
neighbourhood. 
 
Chakraborty et al. (Chakraborty, 1994) combined a region-based method to 
provide an initial segmentation of the image, and then fit a parametrically 
deformable shape model to find the boundary of interesting features in the 
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segmented image.  Ranganath (Ranganath, 1995) used a snake algorithm to 
extract the contour from cardiac MRI studies by propagating the snake to 
sequence of images, with an intermediate processing step. The intermediate 
process prevents the snake contour from becoming trapped in local minima. The 
initial contour is crucial step in the snake algorithm. 
 
6. Multiparametric methods 
Some groups use multiple sets of MRI volumes to have more information on the 
images. For example Jackson and colleagues (Jackson, 1993) described a method 
which segmented the T2 and PD (2-dimensional) histogram into five classes 
corresponding to GM, WM, CSF MS lesions and other tissues using a cluster 
algorithm.  An ellipse enclosing the two standard deviation confidence limits was 
calculated and other parameters of the cluster were derived.  The ellipse could be 
extended or reduced interactively on the scatter plot, while viewing the image.  
Pixels thus classified were displayed in image space.   
A system described by Mitchell and colleagues (Mitchell, 1994) was similar to 
that of Jackson et al. but apparently allowed more interactions.  Mitchell’s 
parameterization of the feature space clusters allowed a location in feature space 
to have graded (fuzzy) membership of a cluster, and also to belong to more than 
one cluster.  This in turn meant that any pixels in the image having the 
(multispectral) intensity properties of a particular feature space location would 
also have the same (multi-tissue) fuzzy membership.   
Zijdenbos et al. (Zijdenbos, 1994) developed a method which used T1 as well as 
T2 and PD data sets. For forming feature space clusters, the user input a set of 
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training points.  A neural network algorithm constructed the clusters.  They 
showed that correction for intensity inhomogeneity had a profound effect on the 
results.  
Johnston et al. (Johnston, 1996) acquired dual echo (PD and T2 weighted) and 
discussed the extent of overlapping intensities of the important tissue classes, but 
they carried out initial segmentation using the intensity histogram of each echo 
separately. Class membership was expressed as a probability or fuzzy value, as 
with Mitchell et al. and Zijdenbos et al. Like other authors, they demonstrated the 
importance of correction for intensity inhomogeneity.  Kamber et al. (Kamber, 
1995)  registered MS patient scans with a probabilistic anatomical atlas.  This was 
then used to guide the lesion segmentation process with a reported high degree of 
agreement with manual segmentations. 
Udupa et al. (Udupa, 1997) have developed an approach to segmentation which 
they term “fuzzy-connectedness” and have applied this to the MS lesion 
quantification on dual echo MR images.  The background is masked by applying a 
threshold which is derived by identifying border voxels in a whole-image 
histogram of gradient magnitudes.  Intensity inhomogeneity is corrected by fitting 
a second order polynomial to a roughly segmented “CSF object”.  This is 
extracted by creating an image from the ratio of T2 and PD values which 
minimises the pre-correction intensity inhomogeneities.  They then use an 
empirical approach to derive parameters from the 2D histogram for the “fuzzy 
connectedness” analysis of white and grey matter.  In this application, fuzzy 
connectedness is an index of intensity similarity between two voxels.  This 
“similarity” is a complex function which is high if the mean intensity of the two 
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voxels is close to a neighbourhood mean, but is reduced if the difference between 
the intensities of the two voxels is close to a neighbourhood mean of differences.  
Fuzzy connected objects are then created by linking voxels which are similar to 
their neighbours; boundaries occur where there are low similarities (i.e. marked 
differences in intensity) which cannot be circumvented. 
 
Among the multiparametric systems is also included a more recently published 
method based on the calculation of relaxation properties of each brain voxel, 
based on signal intensities of MR conventional Spin echo images (T1-w, T2-w 
and PD-w) which allows to recognize and segment both normal brain tissues and 
MS lesions (Alfano, 1997; Alfano, 2000).  
As this method was the basis for the present work, it is described more in detail 
hereinafter in its original implementation. Ameliorations introduced for the 
purposes of the present work are then described (see below section on the first aim 
of the study). 
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A MULTIPARAMETRICAL FULLY AUTOMATED 
SEGMENTATION METHOD FOR MS  
 
Alfano et al. (Alfano, 2000) developed a fully automated segmentation method 
that included the identification and volume measurement of demyelinated white 
matter.   
The method is based a relaxometric characterization of brain tissues using 
calculated R1 (= 1/T1), R2 (= 1/T2) and proton density [N(H)] maps from spin-
echo MR acquisition sequences. The assessment of MS lesion distribution in the 
R1, R2, N(H) space indicated that MS lesion classification using the above 
procedure would require utilization of both relaxometric and geometric features of 
MS lesions for their classification (14). 
 
Generation of the multiparametric maps 
The Alfano’s multiparametric approach requires two sets of slices covering the 
whole brain obtained at 1 or 1.5 T MRI scanner, sampling the whole brain 
contiguously (Fig. 1). Each set includes conventional spin-echo sequences 
providing T1w and PD/T2w  axial images.  
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Fig.1  
The example of one axial slice from the MRI acquisition is displayed showing the contrast 
obtained from the spin-echo sequences. Images represent respectively: T1-weighted on the left, 
PD-weighted in the middle and T2-weighted on the right. 
 
For each slice, relaxation-rate (R1 and R2) and proton-density [N(H)] maps are 
computed according to the following equations: 
 
[1] 
 
 
[2] 
 
where S is MR signal intensity, N(H) is proton density, K is a constant depending 
on total device performance and gain, R1 and R2 are spin-lattice  and spin-spin 
relaxation rates, respectively (with TE1 and TE2 indicating respectively the first 
and the second echo times of the double-echo sequences). Eqs. [1] and [2], 
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respectively valid in the transverse steady state for single-echo and double-echo 
sequences, were derived from the analysis of Bakker and colleagues (Bakker, 
1984). 
  
 
 
 
 
 
 
 
 
Fig. 2 
The example of the three maps derived from the triplet acquisition images of one axial slice 
according to the formulas [1] e [2]. Images represent respectively: R1 on the left, R2 in the middle 
and N(H) on the right. 
 
The three maps can be visualized in one color 
picture by driving the Red, Green and Blue 
channel with the R1, R2 and N(H) values 
respectively. The resulting so-called QMCI 
(Quantitative Magnetic Color Imaging) is 
shown in Fig. 3. 
 
Fig.3  
QMCI image of a representative axial slice. 
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Segmentation procedure 
After being calculated for the whole brain volume, the R1, R2 and N(H) values 
for each voxels of the volume are plotted in a three-dimensional space to identify 
clusters of voxels belonging to different brain tissues. Fig.4 presents the cluster 
distribution of the total brain volume in a normal subject, in which the high 
frequency components were eliminated to better identify clusters of different brain 
tissues. 
 
Fig. 4 
Voxel distribution in the R1-R2-N(H) space of a whole brain volume form a normal volunteer and 
a representative QMCI axial slice. The filtering of the high spatial frequency of the image allows 
to better identify clusters of different tissue types: WM (white matter), GM (gray matter), GP 
(globus pallidus), frWM (frontal WM), toWM (temporo-occipital WM), scWM (subcortical WM). 
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Clusters were interactively defined by expert observers with simultaneous 
comparative assessment of the original signal-intensity MR images, of the 
segmented images and of the cluster distributions. The resulting ROI boxes, as 
published (Alfano, 1997) are reported in Fig.5. 
 
Fig. 5 
Voxel distribution in the R1-R2-N(H) space of a whole brain volume from a normal volunteer and 
a representative QMCI image (lower left). Color scale (top) indicates voxel density. ROIs 
indicated on the R1-R2 plane identifies different brain tissues. 
 
It is evident from Fig.5 that a crucial step in ROI definition is the separation of the 
GM and WM clusters, whereas the CSF cluster seemed to be clearly distinct from 
the other two. The automated procedure for segmentation and volume 
measurements is based on the following steps: (a) preprocessing of the 
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multispectral QMCI images; (b) correction for RF inhomogeneities; (c) 
calculation of GM/WM R2 cutoff and ROI coordinate updating; (d) creation of a 
preliminary 3D segmentation matrix; (e) elimination of the voxels belonging to 
extrameningeal tissues, which may fall in one of the cerebral tissue clusters; (f) 
classification of the remaining voxels; (g) volume calculation and display of the 
segmented images. The result of the segmentation algorithm with the 
classification of each voxel of the brain volume is depicted in Fig. 6. 
 
  
 
 
 
 
Fig. 6 An axial slice showing an example of the 
output of the segmentation program. Color coding 
for segmented images is: GM, gray; WM, white; 
CSF, blue; putamen, green; globus pallidus, bright 
red; muscle, dark red; low N(H) tissues, violet; fat, 
pink. 
 
1. Calculation of GM/WM R1 cutoff 
The algorithm in its published version included a calculation of the GM/WM R1 
cutoff that we modified in the present version of the program as described later 
on. An adjustment of the GM/WM R1 cutoff is necessary, because the separation 
of the GM and WM clusters is critically dependent upon their R1 values. 
Therefore the sum of the R1 histogram for all the slices of the study is obtained 
and smoothed. The two R1 values corresponding to 10% of the maximum of the 
histogram (“feet” of the distribution) are determined as shown in Fig. 7. The 
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GM/WM R1 cutoff value is set at 43% of the distance between the two feet. Such 
value provided the best GM/WM separation in the segmented images in a test 
population of 10 normal subjects (age range: 24 to 57 years) originally used to 
define the position of the normal brain tissue clusters in the multispectral R1, R2 
and N(H) space. The use of a predefined percentage of the distance between the 
edges of each distribution from prefiltered data results in a R1 cutoff value 
tailored to each subjects. 
 
Fig. 7 
Volume study performed in a 28-year-old normal subject: distribution along the R1 axis of voxels 
belonging to GM and WM ROIs in series of representative slices before (A) and after realignment 
(B) and corresponding sum of all histograms before (C) and after realignment (D). Legend 
between A and B indicates slice positions (Z axis offset in mm, cranial-caudal direction). 
 
After determining the ROIs positions in R1-R2-N(H) space that allow to assign 
each voxel to a specific brain tissue based on the test population, the segmentation 
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procedure was applied to a population of a 50 normal subjects to find age 
correlation of fraction tissue volumes (fGM, fWM and fCSF normalized for the 
total intracranial volume obtained from the sum of GM, WM and CSF). 
 
MS plaques automatic segmentation  
The Alfano’s segmentation method has been successfully applied to the 
segmentation of MRI studies from MS patients including in the software the 
automated identification  and volume measurements of demyelinated white 
matter. The assessment of MS lesion distribution in the R1, R2, N(H) space 
indicated (Fig. 8, 9) that MS lesion classification using the previously described 
procedure would require utilization of  both relaxometric and geometric features 
of MS lesions for their classification.  
 
Fig. 8  
Projection of the 3D histogram of brain voxels from the 22 MR studies in normal subjects onto the 
N(H)-R2 (left) and R1-R2 (right) planes. Color scale (right) indicates voxel density. Mean values 
of the plaques from 18 studies in MS patients are superimposed (green dots; intensity is 
proportional to plaque volumes). ROIs indicate respectively: 1, muscle; 2, fat; 3, globus pallidus; 
4, putamen; 5, white matter; 6, gray matter; 7, potentially abnormal white matter; 8, CSF. 
 
R2 
R1 N(H) 
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Fig. 9 
Projection of the 3D histogram of brain voxels onto R1-R2 plane (upper row) and QMCI maps at 
the level of the lateral ventricles (lower row) in a normal subject (left) and in two patients with 
different lesion load. WM 5 white matter, GM 5 gray matter, CSF 5 cerebrospinal fluid. In the two 
patients different degrees of the involvement of periventricular and subcortical WM (dark violet 
areas) are shown. The corresponding R1-R2 distributions show the position of abnormal WM. 
 
1. Identification of WM lesions 
Figure 10 shows a flow chart of the procedures for the classification of WM 
lesions.  
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Fig. 10 
Flow chart of the procedure for the classification of WM lesions. 
 
The classification of normal brain tissues is based on their distribution in the R1, 
R2, N(H) multifeature space, where the clusters of GM, WM, and CSF are well 
defined (Fig. 8, 9). To know the position of the cluster representing the 
demyelinated WM in the multifeature space, a preliminary analysis was 
performed on 18 MR studies in 18 subjects with MS. Three neuroradiologists with 
more than 4 years of experience in brain MRI interpretation, selected WM lesions 
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on original films [T1-, T2-, N(H)-weighted images] in the MS patients. 
Neuroradiologists were asked to identify lesions according to conventional 
diagnostic criteria. A subset of 253 MS lesions (representative of the whole 
spectrum of MR appearance), identified by at least two observers, were then 
outlined on the QMCI slices, using an interactive region growing routine written 
by the authors using Interactive Data Language (Research System, Boulder, CO). 
For each lesion, the mean value of R1, R2, and N(H) were calculated and 
superimposed onto a reference distribution of normal intracranial tissues obtained 
by averaging 22 normal studies (Fig. 8).  
 
In the multifeature space, abnormal WM voxels cover a wide range of R1, R2 
values (Fig. 8) and seem to originate from the normal WM cluster and migrate 
toward lower R1, R2 values. This is more clearly shown when comparing R1, R2 
distributions of normal subject with patients with a different lesion load (Fig. 9).  
Since in the multifeature space the MS lesions partially overlap the normal tissue 
distribution (Figs. 8, 9), voxel position alone does not allow unequivocal 
classification of MS lesions but only permits the definition of a ROI for tissues 
that can be classified as “potentially abnormal white matter” (PAWM). A PAWM 
ROI including the above-mentioned 253 MS lesions was defined (Fig. 9). To 
segment out MS lesions, the segmentation procedure was modified to operate in 
two steps: 
1. GM, WM, CSF, muscle, fat, globus pallidus, putamen, and PAWM voxels 
are classified based on their position in the multifeature space by obtaining 
a presegmented 3D matrix (256, 256, 32). 
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2. The 3D clusters composed of PAWM voxels are classified as lesion or 
normal tissue, taking into account their morphologic characteristics. 
The second step included a) identification of “potential lesions” (PL), b) 
fragmentation of spatial clusters, and c) lesion classification. 
 
1.1 Identification of “potential lesions” 
The presegmented 3D matrix is scanned to find the PAWM voxels forming 
clusters in the physical space, which are then labeled PL. When a PAWM voxel is 
found, a 3D region growing technique is applied, using this voxel as a “seed,” to 
define a spatial cluster formed by spatially contiguous PAWM voxels. 
 
1.2 Fragmentation of spatial clusters 
This step is aimed at improving classification of large lesions. In fact, the 
presence of large lesions increases the probability that normal tissue voxels, 
included in the PAWM, could be spatially connected to true lesion voxels. Thus, 
large PLs probably include thin connections between normal and abnormal 
tissues. PLs larger than 8 ml are broken up into different PL fragments using an 
erosion algorithm that cuts the connections thinner than 3 pixels. 
 
1.3 Lesion classification 
The aim of this task is to classify the spatial clusters based on their shape, 
dimension, and spatial relationship with WM. The criteria used to classify as 
lesion a 3D spatial cluster are based on the assumption that small MS lesions are 
roundish and surrounded by WM, while, as size increases, the shape becomes 
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more irregular, and a large interface with GM can occur. To realize this task, for 
each PL the following parameters are calculated: 
1. PL shape factor (PLSF): 
     
where nb is the number of voxels surrounding the PL, n is the number of voxels of 
PL. 
2. PL dimension factor (PLDF): 
     
3. Surface-volume factor (SVF): 
     
where P1 and P2 are the weight factors determined in the algorithm optimization 
(see below). 
4. Center of mass of PL and of surrounding WM (SWM) in the R1, R2, N(H) 
space according to the formula: 
     
where xi is the i th coordinate of the center of mass of a tissue spatial cluster in the 
multifeature space, and n is the number of voxels of that cluster. 
A PL is classified as lesion if the percentage of surrounding WM (SWM/nb) is 
greater than the surfacevolume factor. The procedure at this stage would 
erroneously classify as lesions some very small spatial clusters (one or two 
voxels) surrounded by normal WM. In fact, since in the multifeature space the 
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PAWM ROI is contiguous to normal WM ROI (Fig. 10), some normal WM 
voxels can fall into PAWM ROI due to noise; being surrounded in the physical 
space by WM, they would be erroneously classified as lesions. 
To avoid this, a PL is classified as lesion only if the following additional 
condition is verified in the normalized R1, R2, N(H) space: 
    
where :  is the vector joining the centers of mass of SWM and PL,  is the unit 
vector oriented from the center of mass of abnormal WM to the center of mass of 
normal WM (obtained from the 40 studies used for optimization of the algorithm), 
D is the lowest distance in the parametric space necessary for detection of a lesion 
(ie, the minimum color contrast to detect a plaque in the QMCI images) according 
to two experienced neuroradiologists (A.B., M.Q.) (D 5 5.4 normalized units). 
The normalization of the multiparametric space was obtained by dividing spatial 
coordinates by NFx, NFy, NFz: 
    
where R1SD, R2SD, and N(H)SD are respectively R1, R2, and N(H) standard 
deviations of a manually selected pure frontal WM distribution in the same space. 
If PL is not classified as lesion, it is classified as GM, WM, or CSF depending on 
its mean R1 and R2. 
 
Validation 
To compare the results of the fully automated segmentation program (hereinafter 
referred to as “unsupervised segmentation”) with manual selection of abnormal 
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WM (reference standard, hereinafter referred to as “supervised segmentation”), 
manual editing of the unsupervised segmentation results was performed using a 
commercial PC-based photo-editing program (Photoshop, Adobe, Mountain 
View, CA). The unsupervised segmentation program calculates normal and 
abnormal tissue volumes and provides segmented images by codifying different 
tissues with different colors (Fig. 11). Furthermore, it adds to each QMCI image, 
besides the three RGB channels containing the R1, R2, and N(H) maps, a fourth 
channel containing a map of the segmented MS lesions that can be displayed, as a 
selection, onto the QMCI images (Fig. 11). The neuroradiologist verifies the 
accuracy of the automated classification by comparison with the original MR 
images and, if that be the case, he/she can interactively modify the selection 
adding WM lesions not identified by the unsupervised method (false negative) or 
deselecting areas incorrectly classified as WM lesions by the unsupervised 
method (false positive). Supervised segmentation results are saved into an 
additional channel of the images, allowing pixel by pixel comparison of different 
segmentation techniques and inter-/intraoperator comparison. 
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Fig. 11 
Axial slices at the level of lateral ventricles in an MS patient with medium lesion load. Column on 
the left multifeature QMCI image are shown where MS lesions appear violet, while column on the 
right corresponding. unsupervised segmented image are displayed. MS lesions are displayed in 
yellow.  
 
In the repeatability studies, to minimize the intraoperator variability (as required 
in clinical trials, when analyzing studies performed before and after therapy), 
simultaneous supervised segmentation of two studies was also performed. This 
type of analysis is hereinafter referred to as “comparative supervised 
segmentation.”  
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To validate the technique, 16 MR studies in MS patients, not previously used for 
algorithm optimization, were analyzed with the unsupervised method and then 
analyzed under supervision by three experienced neuroradiologists. Furthermore, 
for interstudy reproducibility assessment, four patients with heterogeneous lesion 
load underwent two studies within the same day. No special care was taken to 
ensure that the same head and/or slice positioning was obtained in both studies. 
 
1. Specificity of  the method 
For specificity assessment, false-positive lesion volume was defined as the 
amount of abnormal WM detected in ormal subjects (24 MR studies). Mean 
volume of the “apparently abnormal” WM detected  by the unsupervised 
procedure in normal volunteers was 0.11 ml (range 0–0.59 ml). 
 
2. Sensitivity of the method 
Sensitivity was evaluated using the results of supervised segmentation as the gold 
standard: it was expressed as the percentage of WM-lesion voxels, as defined by 
the supervised technique, correctly classified by the unsupervised technique (true 
positive) in the 16 MS patients. In 16 studies in MS patients, not used for 
algorithm optimization, average lesion load was 31.0 ml (range 1.1–132.5). The 
unsupervised method correctly classified as abnormal WM 87.3% of the total 
lesion volume detected using the supervised technique in the 16 patients 
(mean sensitivity per patient 81.2%). In Fig. 5, regression of unsupervised vs. 
supervised technique is displayed. Slope and intercept were respectively 1.08 ± 
0.03 and 1.34 ± 1.34. 
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3. A posteriori correction of GM and WM volumes 
The segmentation technique relays mainly on calculated relaxation rates of 
normal brain tissues, which are fixed for each tissue and relatively independent on 
sequence parameters, to individuate GM, WM, CSF, and MS plaques. The only 
parameter tailored on each study is the R1 cutoff between GM and WM, which is 
calculated at a fixed percentage between the two tissue clusters (see above). 
However, Quarantelli et al. (Quarantelli, 2003) demonstrated the presence of a 
bias introduced in the segmentation of normal brain tissues by the presence of 
aWM (with R1 values comparable to GM), which could in theory modify the 
definition of the R1 threshold between GM and WM clusters.  
The relationship between aWM presence and the accuracy in fractional normal 
tissue volumes and the resulting correction factors were reported with a posteriori 
correction of GM and WM volumes as assessed by linear regression analysis (Fig. 
12). 
 
Fig. 12 
Effect of the presence of aWM on the accuracy of automated measures of fGM (A), fWM (B), and 
fCSF (C) volumes, compared with corresponding fractional volume changes of brain normal 
tissues in MS patients. The fractional volumes are expressed as percentage of their original value 
(measured before aWM addition) for simulated MS studies (filled squares) and as percentage of 
the value expected for patient age in MS studies (empty squares). For simulated data, significant 
regression lines are reported along with corresponding equations and R values. A small although 
significant overestimation of fWM and fCSF and underestimation of fGM is detectable, largely 
below the observed changes in fGM and fCSF in MS patients. 
 38 
BRAIN TISSUE VOLUMES IN MS: PREVIOUS RESULTS 
 
Only a few studies have assessed volume changes in both WM and GM in mixed 
MS population (Liu, 1999) (De Stefano, 2001) and in purely RR (Chard, 2002; 
Ge, 2001; Quarantelli, 2003), but whether they are simultaneously present and 
sizeable is currently debated. Liu et al. reported loss in GM  and WM in both RR 
and SP MS patients, while De Stefano at al. assessed only GM loss (he did not 
search for WM loss) in RR and PP separately. For the groups that studied purely 
RR MS patients, in one case (Ge, 2001) tissue loss appeared limited to WM, 
albeit a significant correlation between GM and abnormal white matter volume 
(aWM) was found, while a second study (Chard, 2002) found a decrease in both 
GM and WM fractions, although lesion load (LL) correlated only with GM loss 
and the third study (Quarantelli, 2003) found  only a GM loss strongly correlated 
with LL. 
Moreover, in a recent study on a group of patients with clinically isolated 
syndromes suggestive of MS (Dalton, 2004) GM loss (but not WM loss) was 
found in the subgroup of patients who developed in 3 years clinically defined MS, 
thus confirming the presence of GM atrophy already in the very early stages of 
the disease.  
Although all of these studies provided consistent evidence that brain atrophy is a 
relevant feature of MS, the differential involvement of WM and GM in patients 
with different disease courses as well as the intercorrelations between WM and 
GM atrophy and lesion load, and the correlations between WM and GM atrophy 
and clinical features, have been only partially defined.  
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In addition none of these studies addresses the question of whether the observed 
tissue loss is homogeneously distributed or rather localized in specific cortical or 
subcortical regions. 
In previous studies assessing brain tissue loss over specific pre-defined brain 
regions, decreases in both area and axonal density in corpus callosum (Evangelou, 
2000) and in thalamic GM (Cifelli, 2002) have been reported. 
Nevertheless, to date a comprehensive look at the GM regional changes has been 
done, to the best of our knowledge, only in one study (Sailer, 2003) using 
automatic surface reconstruction to measure the cortical thickness across the 
entire brain in a group of MS patients, including both RR and secondary 
progressive subtypes of the disease. 
That work reported a highly significant focal atrophy bilaterally in frontal, 
temporal and motor areas in the MS patients, motor cortex involvement being 
related to physical disability. 
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AIM OF THE WORK 
 
Aim of the present work was threefold:  
1. to improve the multiparametric segmentation technique originally 
developed at our laboratory (Alfano’s method) by optimizing GM/WM 
separation to eliminate the bias in favor of WM volumes which had been 
demonstrated in presence of MS lesions. 
2. to quantify cerebral tissue volumes in a large population of MS patients to 
rule out controversies of the updated literature in the field. 
3. to assess whether GM loss in MS is preferentially located in specific brain 
region.  
For the first aim, we implemented a multigaussian fit routine to detect more 
accurately in each study the GM/WM R1 cutoff (i.e. the R1 value separating the 
GM and WM clusters). The resulting optimized segmentation routine was 
validated in a series of simulated MS studies. 
For the second aim we sought to measure WM and GM atrophy and lesion load in 
a large population of patients with MS using the fully automated, operator-
independent, multiparametric segmentation method previously described. The 
intercorrelations between WM and GM atrophy and lesion load and the 
correlations between clinical and MRI data were also assessed. This was 
accomplished by organizing a multicenter study, in which an MRI machine 
housed in a truck traveled to different locations to perform the same MRI protocol 
in all patients. 
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For the third aim we have used the Voxel Based Morphometry (VBM) 
(Ashburner and Friston, 2000), to compare on a voxel-by-voxel basis GM and 
WM volumes as measured by segmentation of conventional spin-echo MR 
images. VBM allows to compare structural features across scans of different 
subjects in a fully automated manner, thus overcoming problems of intra- and 
inter-observer bias and sensitivity, as well as the need for a-priori definition of 
structures of interest. We applied VBM to a selected group of RR-MS patients 
and to an age-matched control group to assess regional GM loss on a voxel-by-
voxel basis. VBM was also used to search for an asymmetric effect of the 
pathology between left and right hemispheres, and to search the whole brain on a 
voxel-by-voxel basis for correlations between local GM volumes and disease 
duration, Expanded Disability Status Scale (EDSS) score and the abnormal WM 
(aWM) volume (hereinafter referred to as lesion load, LL).  
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FIRST AIM: 
OPTIMIZATION OF MULTIPARAMETRIC 
SEGMENTATION FOR MS 
 
To improve the segmentation method, a new technique to calculate GM/WM R1 
cutoff was introduced to eliminate the previously observed slight underestimation 
of fGM in the presence of high LL (Quarantelli, 2003). 
 
Calculation of GM/WM R1 cutoff with multigaussian fitting 
As described in the previous chapter the Alfano’s method was based on an 
adaptive threshold to separate in R1 WM and GM, that was recalculated for each 
study. Once the multiparametric maps were obtained the program calculated the 
histogram in R1 of all the slices in a volume and summed it to obtain an R1 
distribution for each patients. As shown in Fig.12 the R1 resulting distribution for 
a normal subject is characterized by the presence of two peaks, the one to the left 
relative to GM voxel distribution and one to the right relative to WM distribution.  
The presence of a medium-high LL in R1 distribution due to MS plaques changes 
the R1 distribution increasing above normal GM peak and decreasing WM peak 
due to the relaxation properties of MS plaques (see Fig. 9). 
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Fig. 12  
R1 histogram obtained from the sum of the histograms of all slices in a volume from a normal 
subject. In the histogram are clearly distinguishable the GM and WM peaks. The cutoff between 
GM and WM, calculated as described in Alfano et al. (Alfano, 1997) is drawn in purple. 
 
In Fig. 13 the R1 histogram of a representative MS-RR patient with a medium LL 
(LL=3,04% of total ICV) is shown. The cutoff between GM and WM distribution, 
calculated as the 43% of the distance between the two feet moves towards GM 
peak underestimating GM volume in favor of a overestimation of WM volume. 
This is due to the way of calculating the feet of the distribution as the 10% of the 
maximum peak that in the “normal” case is the WM peak, but in the 
“pathological” case could be the GM peak as shown in Fig.13.  
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Fig. 13 
R1 histogram obtained from the sum of the histograms of all slices in a volume from an MS-RR 
patient with a medium lesion load (LL=3,04% of total ICV). In the histogram is clearly shown the 
increase in GM peak due to the migration of MS plaques towards GM R1 values. The cutoff 
between GM and WM, calculated as described in Alfano et al. (Alfano, 1997) is drawn in purple. 
 
To avoid correction a posteriori of the underestimation of GM volumes 
(Quarantelli, 2003) we introduced a new method to calculate GM/WM cutoff 
based on a multigaussina fitting of the R1 histogram based on the hypothesis of a 
Gaussian distribution of GM and WM voxel values. The procedure is now based 
on the following steps: 
• Searching of the GM peak of the R1 distribution (blue line in Fig. 15) 
• Fitting of GM voxel R1 distribution with a Gaussian function with 
constrains based on the rise shape of R1 histagram (purple line in Fig. 15) 
• Subtraction of GM gaussian fit from R1 histogram that gives the WM 
pseudo-gaussian distribution (yellow line in Fig. 15) 
• Calculation of the two feet of the distribution: the right feet equal to 10% 
of GM peak, the left feet equal to 10% for the WM peak. This new way of 
measuring the feet of the distribution stabilize their values even in 
presence of high LL. 
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• Calculation of the cutoff between GM and WM clusters as the 43% of the 
distance between the two feet (cyan line in Fig. 15) 
 
 
 
 
 
 
 
 
Fig. 15 
Multigaussian fitting of the R1 histogram obtained from the sum of the histograms of all slices in a 
volume from an normal subject (blue line). Purple line shows the Gaussian fitting of the GM 
distribution, Yellow line indicates the pseudo-gaussian residual that fit the WM distribution, cyan 
line shows the threshold between GM and WM clusters. 
 
Validation of multigaussian fitting in MS simulated studies 
A validation of the accuracy of normal brain tissue volumes in the presence of 
aWM after the introduction of the multigaussian fitting of R1 histogram was 
performed, to verify the elimination of the slightly underestimation of GM 
volumes in the presence of medium/high LL in MS patients. 
A set of simulated MS studies was thus generated by substituting in 4 NV studies 
variable amounts of WM with plaques selected from 4 MS studies with mid to 
high lesion load. The voxel clusters identified in the MS studies by the 
segmentation program as aWM were substituted to randomly selected areas 
segmented as WM in the 4 NV studies. The procedure was iteratively replicated 
after a 1-voxel 2D erosion of the plaques to generate 37 simulated MS studies 
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with progressively decreasing LL ranging from 230.2 ml to 0 (43 ± 58.7 ml; mean 
± standard deviation). 
The relationship between aWM presence and the accuracy in fractional normal 
tissue volumes were assessed by linear regression analysis (Fig. 16). The measure 
of GM volumes of the simulated data shows a completely recover of GM volume 
with a residual error (slope of the linear regression) that is less than the standard 
deviation of the slope of the linear regression that fits GM loss of the MS 
population. This demonstrated that with the multigaussian fits of the R1 histogram 
for the calculation of  GM/WM cutoff the a posteriori correction of GM and WM 
volumes is not needed anymore. The software for generation of simulated MS 
studies was written using Interactive Data Language (IDL, Research Systems, 
Inc.; Boulder, CO). 
 
 
 
Fig. 16 
Results of the 
simulation procedure. 
Blue dots represents 
fractional GM 
volumes of the MS 
population plotted 
versus fractional 
aWM fitted with a 
linear regression. 
Yellow dots 
represents the results 
of the simulated MS 
studies in the version as published by Alfano et al. (Alfano, 1997) showing the slight 
underestimation versus LL. Pink dots represents the GM volumes of the same simulated data with 
the new version of the algorithm. The slope of the linear regression is smaller that the standard 
deviation of the slope of the linear regression of the GM loss in MS.  
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SECOND AIM: 
QUANTIFICATION OF GLOBAL BRAIN TISSUE VOLUMES 
IN A LARGE POPULATION OF MS PATIENTS 
 
The segmentation method previously described in detail has been applied to 
simultaneously measure in vivo volumes of GM, normal white matter (WM), 
abnormal white matter (aWM), and cerebro-spinal fluid (CSF), and to assess their 
relationship in 50 patients with relapsing-remitting multiple sclerosis by 
Qurantelli et al. (Quarantelli, 2003). That work reported that brain atrophy in RR-
MS mainly relates to GM loss, which in turn correlates with lesion load, global 
WM volume appearing unaffected by the pathology once MS plaque volume is 
taken into account. LL and GM loss, as well as corresponding CSF increase, do 
not appear to significantly affect the clinical status as assessed by EDSS, which 
correlates instead with disease duration. We sought to measure WM and GM 
atrophy and lesion load in a large population of patients with MS of mixed 
courses (RR, PP and SP) using the Alfano’s segmentation method modified as 
described above and to investigate the intercorrelations between WM and GM 
atrophy and lesion load and the correlations between clinical and MRI data. This 
work was accomplished by organizing a multicenter study, in which an MRI 
machine housed in a truck traveled to different locations to perform the same MRI 
protocol in all patients. 
 
Patient recruitment 
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The study design was cross-sectional. During a predefined 6-month time window, 
all consecutive patients with MS, on the basis of a prescheduled visit, and all 
consecutive 20- to 50-year-old sex-matched healthy volunteers were included. 
Patients with definite MS (McDonald, 2001) were recruited from the MS 
outpatient clinics of seven university hospitals (Second University of Naples, 
University “Federico II” of Naples, and Universities of Bari, Catanzaro, Messina, 
Catania, and Palermo) and the regional hospital of Potenza. Because these centers 
supply interferons (IFNs) 
and other immunomodulators to patients with MS, and considering the high 
frequency of treatment in Italian patients with MS, it is likely that the patients of 
our sample are representative of the general MS population. Another selection 
bias may be due to the number of patients who disagreed to participate to the 
study. Indeed, the percentage of refusals was very low (<5%). All enrolled 
subjects were examined on the same day as the MRI session. Criteria for 
excluding patients were ongoing clinical relapse, other major medical illnesses, 
history of substance abuse, and corticosteroid treatment within 12 weeks of the 
start of the study. Criteria for excluding volunteers were neurologic disorders, 
major medical illnesses, history of substance abuse, and current drug treatment. 
Seven hundred thirty-three subjects took part in the study: 629 patients with MS 
and 104 control subjects. Thirty-two patients with MS were not included in the 
final analysis because they did not complete the MRI exam or because of motion 
artifacts, so the study results are based on 597 patients with MS and 104 control 
subjects. The protocol was approved by local ethics committees. All participants 
gave written informed consent. 
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MRI studies 
The same MRI protocol was performed in all subjects using the same MRI 
scanner (1.0 T Genesys Signa; GE Medical Systems, Milwaukee, WI). For each 
study, two interleaved sets of 15 slices (4 mm thick) covering the entire brain 
were acquired, using for each set two conventional spin echo sequences 
(repetition time/echo time [TR/TE] 600/15 milliseconds, two averages; TR/TE 
2300/15 – 90 millisecond dual-echo sequence, one average; both with 90° flip 
angle and 256 x 192 matrix). All the studies were segmented using a the fully 
automated Alfano’s method, based on relaxometric characterization of brain 
tissues. The program gives complete sets of multifeature images (R1 [=1/T1], R2 
[= 1/T2], proton density [N(H)-based]) and segmented images and calculates the 
volumes of the following intracranial tissues: CSF, GM, normal appearing WM, 
abnormal WM (aWM), and global WM (gWM; calculated as the sum of normal 
appearing WM and aWM). To normalize for head size variability, the volumes of 
intracranial tissues were expressed as fractions (f) of the intracranial volume, 
which were calculated for each subject as the sum of all intracranial tissues. 
faWM is a measure of lesion load as determined by the R1, R2, and N(H) 
information and morphologic characteristics, the reduction of fWM indicates WM 
atrophy, and the reduction of fGM indicates GM atrophy.  
For each study, a couple of interactive interslice movies of both multispectral and 
segmented images were produced, and two neuroimaging experts reviewed them 
(for a maximum of 2 minutes) to detect motion artifacts and segmentation errors 
due to the imperfect separation of nasal mucosa and vitreous humor from brain 
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issue. In 111 studies (15.8%) in which nasal mucosa or vitreous humor was 
erroneously classified as GM or CSF, manual cuts of thin connections between 
intra- and extracerebral tissues in the multispectral image set were performed, 
allowing the program to outcome correct segmentation and volumetry. 
 
Results of the segmentation of a large population of MS patients 
The study population of patients with MS consisted of 383 women and 214 men 
(women/men ratio = 1.8) ages 16 to 68 years (mean ± SD 38.1 ± 10.3 years). 
Their age at disease onset was 10 to 61 years (28.4 ± 9.1 years), and their EDSS 
scores19 were 0 to 8.5 points (2.99 ± 1.7 points). Disease duration was 9.73 ± 
7.26 years, and number of relapses in the previous 2 years was 1.04 ± 1.3. The 
clinical course was RR in 427 (71.5%), SP in 140 (23.5%), and PP in 30 (5.0%). 
EDSS score was = 3.5 in 452 patients (88.3% RR, 7.5% SP, 4.2% PP), between 4 
and 6 in 110 patients (22.7% RR, 60.9% SP, 16.4% PP), and = 6.5 in 35 patients 
(57.1% SP, 42.9% PP). 
Measurements of segmented MRI volumes in the patients with MS and controls 
are presented in Fig. 17. fGM (blue dots), fWM (yellow dots) and CSF (pink dots) 
of MS patients are plotted versus faWM with the corresponding linear regression 
fitting. fGM and fCSF values are age-corrected based on fGM and fCSF volume 
changes with age derived from NV populations. fWM do not show any change 
with age and do not need to be corrected. As depicted in Fig. 17 both fGM, fWM 
loss in MS patients are strongly correlated with faWM ( p < 0.001) with a 
corresponding increase in fCSF. 
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In patients with MS, the mean value of faWM was 1.4% 95% CI 1.3 to 1.5), 
which corresponds to a lesion load of about 17 cm3 in an average brain of 1200 
cm3. fWM was (p < 0.001) reduced in patients with MS by 1.3% (95% CI 0.5 to 
2.1), which corresponds to a volume loss of about 15.6 cm3 in an average brain of 
1200 cm3. fGM was reduced (p < 0.001) in patients with MS by 2.1% (95% CI 1.4 
to 2.8), which corresponds to a volume loss of about 25 cm3 in an average brain of 
1200 cm3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17 
Scatterplot of fGM (blue dots), fWM (yellow triangles), and fCSF fraction (pink boxes), vs faWM. 
fGM and fCSF values are adjusted to patients mean age (38.3 years). Where significant, regression 
lines are reported along with the corresponding equations and R values. Increasing loss of GM and 
WM (which includes also the WM lesion volume) with corresponding increase in CSF is apparent 
with increasing faWM. 
 
Table 1 shows the comparisons of segmented MRI volumes in patients with MS 
with different disease courses. Between-group comparisons showed significant 
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differences of MRI parameters only in RR patients with respect to SP patients. 
Both fWM and fGM were significantly lower in the SP group than in the RR 
group. The magnitude of the fWM reduction was similar to that of fGM, being 
1.4% (95% CI 0.8 to 2.0) for both. Furthermore, faWM was significantly higher in 
the SP group than in the RR group (0.7%; 95% CI 0.3 to 1.1). 
  Mean (95% CI     
 RR, n=427 SP, n=140 PP, n=30 RR vs SP RR vs PP SP vs PP 
faWM 1.2 (1.0-1.4) 1.9 (1.6-2.2) 1.8 (1.2-2.5) <0.001 NS NS 
fWM 34.2 (33.9-
34.5) 
32.8 (32.3-33.4) 33.1 (31.9-34.2) <0.001 NS NS 
fGM 51.4 (51.1-
51.7) 
50.0 (49.4-50.5) 50.7 (49.2-51.5) <0.001 NS NS 
* Adjusted for age, sex, and education 
Table 1 
Comparisons of adjusted* MRI volumes (as % of whole brain volume) for different MS courses 
RR= relapsing-remitting, SP= secondary progressive, PP= primary progressive, AWM-f=abnormal 
WM fraction, gWM-f = global WM fraction, GM-f= GM fraction 
 
From the multivariate correlations of MRI fractions with clinical features, three 
significant predictors of lesion load were obtained: EDSS, age at disease onset, 
and drug treatment (IFNβ vs never treated). The strongest predictor was disability: 
a 1-point increase in the EDSS score corresponded to about a 0.24% increase of 
faWM 2.9 cm3 for an average brain of 1200 cm3). Furthermore, a 0.15% increase 
of faWM was found for each 5 years earlier that the MS had its onset. 
IFNβ-treated patients had a higher lesion load (adjusted mean of 1.6%; 95% CI 
1.4 to 1.7) than did patients who had never been treated (1.2%; 95% CI 1.0 to 1.5, 
p < 0.008). 
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With regard to WM atrophy, the strongest predictor was age at onset followed by 
disability: a 0.45% decrease of fWM was found for each 5 years earlier of MS 
onset. Furthermore, a 1-point increase in the EDSS score corresponded to about a 
0.41% decrease of fWM(about 5 cm3 for an average brain of 1200 cm3). 
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THIRD AIM: 
REGIONAL ANALYSYS OF GRAY MATTER AND WHITE 
MATTER LOSS IN RELAPSING-REMITTING MULTIPLE 
SCLEROSIS  
 
In the final part of the work we addressed the question of if and where GM and 
WM loss in MS patients is localized by means of  optimized Voxel-Based 
Morphometry method applied to MRI studies of a population of  patients with 
clinically defined Relapsing-Remitting MS and a population of age-matched 
normal subjects, segmented into normal and abnormal brain tissues using the 
modified version of Alfano’s method described above. Segmented GM and WM 
volumes where subsequently compared on a voxel-by-voxel basis to highlight 
regions of relative GM and WM loss (p<0.05, corrected for multiple comparisons 
at AnCova). 
Additionally, localized differences in brain asymmetry between the MS and the 
control groups were assessed by comparing on a voxel-by-voxel basis maps of 
GM differences between the two hemispheres (p<0.05 corrected for multiple 
comparisons). 
 
Subjects 
Eighty-three patients with clinically defined multiple sclerosis according to Poser 
criteria (Poser, 1983) with a RR course (Lublin and Reingold, 1996)  (54 female) 
and thirty-four normal volunteer (NV, 15 female) were recruited in the study. The 
mean age of the patient group was 38.6 ± 7.5 years (age range 17 – 58), with a 
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mean disease duration of 11 ± 6.8 years (range 0 – 34) and a median EDSS 
(Kurtzke, 1983) score of 2.6 (range 1 – 6). All patients had been previously 
treated only by brief courses of steroids during clinical exacerbations. Mean age 
of the NV group was 43.2 ± 13.2 (range 22 – 69). Exclusion criteria for NV were 
evidence of cardiovascular, metabolic, neurological, and psychiatric impairment, 
as well as abnormal MRI examination. All MS patients and NV were right-
handed. 
Both NV and MS patients agreed to participate in the study by signing a written 
informed consent, and the ethical committees of participating Institutions 
previously approved the protocol. 
 
MRI studies 
MRI protocol included two interleaved sets of 16 slices each covering the whole 
brain obtained at 1.5 T (Intera, Philips Medical Systems, The Netherland), 
sampling the brain at a total of 32 contiguous levels. Each of the two sets included 
conventional spin-echo sequences providing T1w (520/15 msec TR/TE) and 
PD/T2w (1800/15-90 msec TR/TE) 4mm-thick axial images (24cm FOV, 
256x256 acquisition matrix). Images from all studies were segmented using 
Alfano’s method in the modified version previously described. 
 
Optimized VBM 
Voxel Based Morphometry (Ashburner and Friston, 2000) was used in an 
optimized version (Good, 2001b) to process and analyze segmented GM and WM 
maps using Statistical Parametric Mapping software (SPM2, Wellcome 
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Department of Cognitive Neurology, London, UK, www.fil.ion.ucl.ac.uk/spm) 
(Friston, 1995) running under MATLAB version 6 (the Mathworks, Inc., MA, 
USA). 
To minimize potential normalization problems related to differences of 
registration to the standard space between normal and pathological brains (Karas, 
2003), we created a site- and study-specific template. This was done by firstly 
normalizing the segmented GM volumes of each subjects (both NV and MS) to a 
standard space with a 12-parameter affine model without any nonlinear 
component (Ashburner, 1997). The GM prior provided with SPM2 was used as 
standard space model. The resulting roughly normalized GM images of all the 
subjects were averaged, and the resulting volume was smoothed with a Gaussian 
filter of 8 mm full-width at half-maximum (FWHM) (Fig. 18). Nonlinear 
components were not used for template creation in order to preserve group affine 
geometry (Woods, 1998). 
 
The use of a site- and group-specific template, created including both normal and 
pathological volumes, reduces systematic registration bias to any of the two 
groups. 
GM maps of each subject were then normalized to the GM specific template by 
performing affine registration and 16 nonlinear iterations using 6 x 8 x 6 basis 
functions to account for global nonlinear shape differences (Ashburner and 
Friston, 1999). Normalized images were resampled by trilinear interpolation to 1 
x 1 x1 mm voxel size. In addition WM maps were normalized by means of the 
GM normalization matrices and resampled by trilinear interpolation to 1 x 1 x 1 
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mm voxel size. The use of GM normalization matrices for WM analysis, rather 
than building a WM specific template, was choose to minimize normalization 
errors since GM normalization matrices gave more reperee on head shape. 
For each patient study, we also applied the GM-derived normalization matrix to 
corresponding aWM volume and averaged the resulting normalized aWM 
volumes to visually assess plaque distribution in our patient population (Fig.18), 
and to derive left and right hemisphere lesion load for subsequent symmetry 
analysis (see below). 
 
Fig. 18  
Mean of the normalized distribution of aWM in the patient population (in colour scale) 
superimposed to the unsmoothed GM template (in greyscale). Images are scaled to their own 
maximum. Plaques are almost symmetrically distributed and concentrated more toward the 
posterior part of the brain leaving the centrum semiovalia almost unaffected. 
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Since nonlinear normalization implies that certain regions of the brain expand or 
contract to match the template, it was important to correct for the effect of these 
deformation onto regional volumes, as our goal was to assess regional change in 
GM and WM volumes. This was done by “modulating” the voxel values of the 
normalized maps to preserve the total tissue volume in the images, meaning that 
areas that were expanded during normalization were correspondingly reduced in 
values to preserve the information on their original size while the values of the 
voxels from shrunken areas were correspondingly increased. 
Modulation was performed by multiplying GM and WM voxels by the Jacobians 
derived from spatial normalization to preserve the amount of the specific tissue in 
each voxel (Ashburner and Friston, 2000). 
Finally, modulated images were smoothed with a 12-mm FWHM isotropic 
Gaussian filter to reduce confounding by individual variations in gyral anatomy 
and to render the data more normally distributed as per the Gaussian random field 
model underlying the statistical process used for adjusting p values (Ashburner, 
1997). 
It should be noted here that the optimized VBM method, as described in literature, 
implies a preliminary iterative normalization/segmentation procedure to improve 
the accuracy of segmentation. This was however not needed in our case, as the 
segmentation technique that we used is not based on prior probability distributions 
in a normalized space, and as such does not need a preliminary normalization to 
create site-specific GM, WM and CSF priors. 
Also the erosion/dilation procedure described by Karas at al. (Karas, 2003), 
introduced in optimized VBM to eliminate the misclassification of voxels lying at 
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the interface of ventricular CSF and periventricular white matter, was not needed 
in our case as this segmentation error was not appreciable in our GM maps 
(Fig.18). 
 
Statistical analysis 
The effect of the disease onto GM volumes was preliminarily tested by stepwise 
multiple regression analysis using SPSS (SPSS Inc., Chicago, Il, USA). Total 
intracranial volume (ICV, derived from the sum of GM, normal WM, abnormal 
WM, and CSF), age and sex were entered first in the model to account for the 
possible effects of these variables. 
Subject group (NV versus MS patient) was then entered to explore the effect of 
the disease. 
Normalized modulated GM and WM maps were statistically analyzed using the 
general linear model based on the random Gaussian field theory (Friston, 1995). 
The design matrix was constructed to test for regional differences in GM and WM 
respectively between RR-MS group and normal subjects. To take into account 
their effect on brain tissue volumes, age and sex were entered as nuisance 
regressors (confounding covariates) in an analysis of covariance (AnCova), while 
ICV was entered in the model to normalize for head size (Friston, 1995). Prior to 
regression analysis scans were thresholded at 40% of global intensity to reduce 
the influence of any remaining non-brain tissue. This analysis allows to test for 
morphological differences between the two groups across the whole brain on a 
voxel-by-voxel basis; a threshold of p<0.05 was used, corrected for multiple 
 60 
comparisons at the voxel level. Both positive (NV > MS) and negative (NV < 
MS) contrasts were calculated. 
The effect of LL and clinical parameters (EDSS and DD) onto GM volumes was 
preliminarily assessed by performing VBM on subgroups of MS patients defined 
based on clinical parameters.  
To test for effect of LL,  MS patients were divided in two groups: 59 patients with 
LL < 2% of total ICV (mean = 0.94 %, range 0.07 – 1.97) and 24 patients with LL 
> 2% of ICV (mean = 3.53%, range 2.12 – 7.08). The cutoff of 2% was the mean 
value of the total population. 
To test for the effect of DD, MS patients were divided into three groups of almost 
equal size: 30 patients with DD < 8 years (mean = 4.4 yy,  range 0 – 7.8), 26 
patients with 8 < DD < 13 years (mean = 10.68 yy, range 8.1 – 12.7), 27 patients 
with DD > 13 years (mean = 18.8 yy, range 13 – 33.3). 
To test for the effect of EDSS patients were divided in two groups: 53 patients 
with EDSS ≤ 2.5 (mean = 2.01, range 1 – 2.5). The cutoff was selected to separate 
mild to moderate severity. 
Each of the above group was statistically compared on a voxel basis to the NV 
group. 
Additionally, voxel-wise linear regression analysis between probability of grey-
matter and EDSS, disease duration, and LL, was performed with age and sex as 
nuisance covariates, to identify clusters of voxels whose grey-matter density 
relates to these parameters; a threshold of p<0.05 was used, corrected for multiple 
comparisons at the voxel level.  
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Analysis of brain asymmetry 
Localized GM loss, if preferentially located on one side of the brain, would alter 
the physiologic asymmetry pattern of the normal brain. 
To explore this possibility, we checked for differences in brain asymmetry 
between the MS and the control groups by using an analysis technique similarly to 
what previously done by Luders et al. (Luders, 2004). 
First, a symmetric site- and study-specific template was created by flipping left-
right the GM normalized images from all subjects used to create the GM template 
for VBM. The resulting normalized flipped GM images of all the subjects were 
averaged together with the unflipped ones and smoothed with a Gaussian filter of 
8 mm full-width at half-maximum (FWHM) to create a symmetric GM template 
(Good, 2001a; Luders, 2004). The GM original images of all the subjects were 
normalized to the symmetric GM specific template by performing affine 
registration and 16 nonlinear iterations using 6 x 8 x 6 basis functions as for 
optimized VBM. Normalized images were modulated and resampled by trilinear 
interpolation to 1 x 1 x1 mm voxel size. To verify for the presence of statistically 
significant differences in asymmetry between MS and NV groups we generated 
for each subject a new set of images, the Asymmetry Index maps, as described in 
detail by Luders et al. (Luders, 2004), that represent the GM differences between 
the two hemispheres. The Asymmetry Index maps of the two groups were 
compared using a one-way analysis of covariance (AnCova) with age and sex 
entered as nuisance variables. 
This analysis was meant to integrate the VBM analysis by exploring, if localized 
GM loss was detected, if it was significantly lateralized, a condition which would 
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induce a significant difference between the asymmetries of MS group respect to 
NV. The statistical map was thresholded at a level of p<0.05, corrected for 
multiple comparisons. 
Additionally, hemispheric lesion loads were tested to detect any asymmetry in 
aWM distribution between the two hemispheres using paired t-test.  
 
Results 
The preliminary analysis of global GM volumes confirmed previous findings 
(Chard, 2002; Quarantelli, 2003) of GM loss in MS patients as compared to NV 
(607.7 ± 66.1 ml vs. 660.1 ± 49.7 ml, respectively corresponding to 45.7% and 
47.0% of ICV), the difference being significant at multiple regression analysis 
(p<0.001). WM loss also in our population of MS patients results reduced as 
compared to NV (499.8 ± 64.9 ml vs. 562.2 ± 66,8 ml, respectively corresponding 
to 37,4% and 39.88% of ICV) 
MS patients showed a moderate LL, aWM volume being 22.8±18.8 ml (range 1.8 
84.9). 
In figure 18 the site- and study-specific unsmoothed GM template is displayed in 
greyscale. Superimposed in colour scale is the average distribution of aWM in the 
83 MS studies, showing a mostly supratentorial, periventricular symmetric 
distribution. Clusters of significant GM loss in RR-MS as compared to NV after 
correcting for age, sex and ICV are illustrated in figures 19 and 20. Significance 
level is set at p < 0.05, corrected for multiple comparisons at voxel level. 
 
 
 63 
Fig. 19  
Regions of significantly 
reduced cortical GM 
volume in RR patients 
(p<0.05 corrected for 
multiple comparisons at 
voxel level, i.e. T-score > 
4.79) as compared to 
normal subjects. 
Significant clusters are 
overlaid in colour scale 
onto the surface of a single 
subject normalized brain. 
 
 
Fig. 20  
Axial sections (patient’s left side is on the observer’s left side) from selected levels of the 
unsmoothed GM template (in greyscale). The regions of significant GM loss in MS patients are 
overlaid (in yellow). 
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For each cluster, the size, involved Brodmann Areas (BA) and the Talairach 
coordinates of the peak are reported in Table 2. 
Clusters of significant GM loss in RR-MS patients were located predominantly in 
the left dorso-lateral frontal lobe, including motor area (BAs 4 and 6) extending 
into the transverse temporal gyrus (BA 41), as well as Brodmann areas 8, 9 and 
44. 
Other clusters of significant GM loss were located bilaterally in the anterior 
cingulate gyrus (BA 24) and caudate heads, as well as in the left precuneus 
(BA19) extending into the left parietal lobule (BA 40) and cuneus (BA 7), left 
insula (BA 13) extending into superior temporal gyrus (BA 22) and right 
postcentral gyrus (BA 3).  
The search for inverse contrasts (increase tissue volumes in MS patients) did not 
show any significant region. 
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     Coordinates (mm) 
Region Side BA N. voxel T x y Z 
Precentral Gyrus L 4/6 20085 6.96 -32 -24 52 
Transverse Temporal Gyrus L 41      
Middle Frontal Gyrus L 9/8 3080 6.41 -42 22 33 
Precentral Gyrus L 44      
Inferior Frontal Gyrus L 9      
Superior Frontal Gyrus L 6      
Cingulate Gyrus bilateral 24 3251 5.97 -4 3 35 
Caudate Head L n/a 910 5.97 -7 14 1 
Precuneus L 19/31 1703 5.85 -30 -76 79 
Parietal Lobule L 40/7      
Cuneus L 7      
Postcentral Gyrus R 3 323 5.56 59 -14 45 
Insula L 13 680 5.31 -44 13 0 
Superior Temporal Gyrus L 22 
     
Caudate Head R n/a 217 5.28 9 15 -2 
 
Table 2  
Clusters of significant GM loss in RR-MS patients, relative to controls. For each cluster are 
reported the extension and the corresponding Brodmann Areas (BA) in which local maxima are 
located, along with the coordinates in the Talairach space (Talairach and Tournoux, 1988) and the 
T level of the most significant voxel. 
n/a: not applicable 
 
The results of the  GM asymmetry analysis are displayed in Figure 21. A cluster 
of reduced GM is present on the left in MS, extending  from pre-rolandic cortex to 
the superior temporal area, co-localized with major GM loss regions, , confirming 
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a preferential left-sided GM loss at this level. aWM did not show a significantly 
asymmetric distribution across the two hemispheres, left hemisphere containing  
49.0% ± 12,2% of LL, the difference between the two hemispheres not being 
significant at paired  T-test (P=0.53). 
 
Fig. 21  
Region of significant 
differences in GM asymmetry 
in RR patients (p<0.05 
corrected for multiple 
comparisons, i.e. T-score > 
4.93) as compared to normal 
subjects. The significant 
cluster of reduced GM in RR 
patients is overlaid in colour 
onto the surface of a single 
subject normalized brain. 
Contours of the regions of 
GM loss resulting from VBM 
analysis are overlaid in blue. 
 
No significant correlation emerged between regional GM volume EDSS and 
disease duration. 
Results of the voxle-wise linear regression analysis between GM loss and LL is 
shown in Fig. 23 (p<0.05 was used, corrected for multiple comparisons at the 
voxel level). 
Regions of significantly reduced cortical GM volume in RR patients that linearly 
correlated with LL are preferentially located at the level of right and left caudate 
heads, left hippocampus, right and left primary motor areas and left and right 
frontal lobe. 
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Fig. 23 
Regions of significantly 
reduced cortical GM volume 
in RR patients that linearly 
correlated with LL (p<0.05 
corrected for multiple 
comparisons at voxel level, 
i.e. T-score > 4.63). 
Significant clusters are 
overlaid in colour scale onto 
the surface of a single 
subject normalized brain. 
 
 
Clusters of significant GM loss in the subgroups of MS patients on the basis of 
their LL, DD and EDSS as compared to NV after correcting for age, sex and ICV 
are illustrated respectively in figures 24, 25 and 26. Significance level is set at p < 
0.05, corrected for multiple comparisons at voxel level.  
 
Fig. 24  
Regions of significantly reduced cortical GM volume in two subgroups of RR patients: A) 59 
patients with LL < 2%, B) 34 patients with LL > 2% (p<0.05 corrected for multiple comparisons at 
voxel level, i.e. T-score > 4.7). Significant clusters are overlaid in colour scale onto the surface of 
a single subject normalized brain. 
A) B) 
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Fig. 25 
Regions of significantly reduced cortical GM volume in three subgroups of RR patients: A) 30 
patients with DD < 8 years,  B) 26 patients with 8 < DD < 13 years, C) 27 patients with DD > 13 
years (p<0.05 corrected for multiple comparisons at voxel level, i.e. T-score > 4.7). Significant 
clusters are overlaid in colour scale onto the surface of a single subject normalized brain. 
 
 
Fig. 26 
Regions of significantly reduced cortical GM volume in two subgroups of RR patients: A) 53 
patients with EDSS < 2.5,  B) 30 patients with EDSS > 2.5 (p<0.05 corrected for multiple 
comparisons at voxel level, i.e. T-score > 4.7). Significant clusters are overlaid in colour scale onto 
the surface of a single subject normalized brain. 
A CB
A) B) 
 69 
 
For all of the parameters tested regions of significantly reduced GM as LL, EDSS 
and DD increase showed a good co-localization with GM reduced regions of the 
entire population. 
Clusters of significant WM loss in RR-MS as compared to NV after correcting for 
age, sex and ICV are illustrated in figure 22. Significance level is set at p < 0.05, 
corrected for multiple comparisons at voxel level. WM loss is almost 
symmetrically distributed and preferentially located at the level of supratentorial 
periventricular regions. 
 
Fig. 22 
Regions of significantly reduced WM volume in RR patients (p<0.05 corrected for multiple 
comparisons at voxel level, i.e. T-score > 5.12) as compared to normal subjects. Significant 
clusters are overlaid in colour scale onto the MR volume studies of  a single subject normalized 
brain. 
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DISCUSSION 
 
In this work, a fully automated segmentation technique was used in an optimized 
version in a large MS population to assess both WM and GM atrophy and lesion 
load as well as to investigate the intercorrelations between MRI measurements of 
atrophy and lesion load and the correlations between clinical and MRI data. 
We have also applied an optimized VBM method to a selected group of RR-MS 
patients to investigate regional GM and WM loss in this specific disease subtypes. 
Our results demonstrated a preferential left-sided fronto-temporal GM loss, with 
other areas located  in the left precuneus and bilaterally in anterior cingulate gyrus 
and caudate nuclei. 
These results integrate previous findings demonstrating global GM volume 
reduction selectively in RR MS (Chard, 2002; Ge, 2001; Quarantelli, 2003). 
However, before discussing findings both on global values and in the 
localization/lateralization of GM loss, as well as possible implications on our 
understanding of the underlying mechanisms, some methodological issues, 
pertaining to both segmentation and VBM, should be examined. 
 
Methodological Issues: segmentation 
We used a fully automated procedure, based on segmented 2D conventional SE 
MR images, which is suitable for the analysis of data from large clinical trial, 
which typically do not include high-resolution 3D volumes. With this respect it is 
of note that the accuracy of the multiparametric segmentation method when 
analysing 4mm thick slices has been validated in previous work (Alfano, 1998), 
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while the use of 4mm thick slices is unlikely to affect VBM, which includes a 
three times larger smoothing (12mm FWHM). 
The multiparametric segmentation method was modified to increase the 
robustness of GM/WM separation in presence of aWM, demonstrating over 
simulated MS studies a high degree of accuracy in determining the GM volume. 
Although a region-specific lesion-associated segmentation bias may still be 
present in our data, it should be considered that such an error would result in a 
regional GM loss strongly correlated with LL, a finding which is not present in 
our results, apart from the caudate nuclei, which however have been demonstrated 
to be affected also using manual parcellation methods (Bermel, 2003). 
Consequently, these results are not explained by a region-specific lesion-
associated segmentation bias. 
Also, the presence of juxtacortical plaques could in theory have biased our results 
by inducing underestimation of the adjacent grey matter. However the assessment 
in the same standard space of the regions of GM loss and of the mean aWM 
distribution suggests that this is not the case at least for the frontal cortex, which is 
far from the bulk of the LL, located in the periventricular region. 
Finally, the presence of intracortical lesions may additionally have induced 
individual variability in the GM by altering the segmentation of adjacent GM, 
introducing an inter-individual local variability that may partly obstruct the 
detection of local GM differences. It should be however considered that signal 
intensity changes in intracortical plaques are subtle at MRI (Kidd, 1999), reducing 
their possible effects onto the segmentation procedure, especially in a population 
with a relatively low lesion load as in this case. 
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Methodological Issues: VBM 
Several factors may affect the capacity of VBM to detect regional GM loss, 
including physiological inter-individual variability in the NV cohort (which may 
preclude the detection of subtle changes in MS patients), the heterogeneity 
intrinsic to the pathology (which may be enhanced when different disease 
durations are included), and noise of the measurement (derived from noise of the 
MR images and from segmentation and normalization errors). Additionally, it 
should be considered that all these factors may in principle have a different effect 
in different areas of the brain which in turn may render VBM differently sensitive 
to atrophy in different areas of the brain. 
However the relative sparing of the occipital lobe and of the infratentorial regions, 
emerging from our findings, is compatible with previous studies showing a 
significant preservation of infratentorial structures in MS patients with mixed 
disease courses (Sailer, 2003), as well as in RR-MS as compared to secondary 
progressive MS patients (Edwards, 1999). 
 
Global tissue volumes 
Overall, compared with controls, patients with MS had more atrophy of both WM 
(−1.3%) and GM (−2.1%), and the burden of MS on brain volume, with respect to 
an average brain of 1200 cm3, can be summarized by the appearance of 17 cm3 of 
faWM and by the lack of about 16 cm3 of fWM and 25 cm3 and of fGM. In more 
detail, patients with MS lost 17 cm3 of WM because of MRI-identifiable lesions 
(faWM) and 16 cm3 because of volumetric measurable atrophy (fWM). Our 
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results are in agreement with previously published data (Chard, 2002) which 
described, in 26 patients with MS, a significant reduction of both WM 
(approximately −4.9%) and GM fractions (approximately −2.8%). The slight 
differences in the amount of WM and GM atrophy may be due to a large 
difference in the number of patients studied, although a difference in the 
segmentation methods cannot be ruled out. In a small group of RR patients, the 
loss of parenchymal volume in RR MS was predominantly confined to WM (Ge, 
2001). With use of the same segmentation method in 50 patients with RR MS, a 
significant reduction of fGM was found, whereas fWM was not significantly 
different between patients and control subjects (Quarantelli, 2003). The lack of 
significant WM atrophy may be due to the small sample of RR patients studied.  
A T1-weighted segmentation method was used to separate segmented GM into 
neocortical and non-neocortical in 90 RR and PP patients, and a significant 
reduction of neocortical GM was found in both groups of patients (De Stefano, 
2003).  
Compared with previous studies, we produced more comprehensive evidence that 
there is significant atrophy of both GM and WM in patients with MS, thus 
confirming the pathologic evidence (Cifelli, 2002; Kidd, 1999; Peterson, 2001; 
Trapp, 1998) of GM involvement in MS. 
Among the studies based on automated MR segmentation methods, only one (De 
Stefano, 2003) assessed differences between patients with different disease 
courses and found no significant differences in neocortical GM between RR and 
PP patients. In our work, we showed that SP patients, with respect to RR ones, 
have significantly more atrophy of both GM and WM, thus suggesting that brain 
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atrophy may be relevant in determining the course of the disease and eventually 
disease progression. No differences were found in the small group of PP patients. 
So far, the intercorrelations between lesion load and WM and GM have been only 
partially addressed. 
In 26 patients with MS, T1- and T2-weighted lesion volumes were inversely 
related to fGM but not to fWM (Chard, 2002). In 50 RR patients, faWM was 
inversely correlated to fGM but not to global fWM (Quarantelli, 2003). In patients 
with RR MS, a significant correlation between neocortical atrophy and T2 lesion 
volume was found, whereas no correlation was found in PP patients (De Stefano, 
2003). We showed that lesion load is significantly correlated with both GM and 
WM atrophy; however, a significantly stronger relationship was found with fGM 
than with fWM. These results support the hypothesis that GM atrophy is heavily 
dependent on lesion load, possibly owing to retrograde degeneration of GM 
neurons secondary to  fibers traversing WM lesions (Ge, 2001) (Bozzali, 2002), 
although we cannot ignore the possibility of both discrete and diffuse independent 
GM lesions that may be undetectable by conventional MRI (Peterson, 2001) 
(Kidd, 1999). Measurements of MRI-segmented volumes were significantly 
correlated to disability and age at disease onset and, to a lesser extent, drug 
treatment. So far, the studies addressing the relationship between MRI and 
disability have reported conflicting results, and this has been attributed to the poor 
sensitivity of the EDSS, although, more recently, functional MRI studies (Filippi 
and Rocca, 2003) suggested that the possible impact of plasticity may play a key 
role in determining the resulting disability. Significant correlations between 
disability and WM and GM atrophy were not found in 30 patients with RR MS 
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(Ge, 2001). A significant correlation between neocortical atrophy and EDSS was 
described in both RR and PP patients, whereas the correlation with disease 
duration was found only in RR patients (De Stefano, 2003). A significant 
correlation between GM atrophy and EDSS was reported, but there was no 
correlation between WM atrophy and disease duration (Chard, 2002). We 
produced very strong evidence that lesion load and both WM and GM atrophy are 
significantly correlated with disability. The existence of a close relationship 
between GM atrophy and disability is further supported by the significant 
association found in the analysis of predictors of disability. This correlation 
supports the role that GM involvement may play in the pathogenesis of MS and 
urges us to focus on neurodegeneration as a key feature of MS. 
The correlation with age at disease onset suggests that the younger the age at 
disease onset, the worse the lesion load and brain atrophy (especially of WM) will 
be. These data suggest that brain atrophy is related to what happens at the very 
beginning of the disease rather than during the disease course. This hypothesis is 
in accordance with previous reports. Global brain atrophy (as derived from the 
parenchymal fraction) and central atrophy (as derived from the ventricular 
fraction) were longitudinally measured in 83 patients with MS at an interval of 2 
to 4 years (Kalkers, 2002). The main observations were that clinical 
characteristics (such as duration of symptoms and ∆EDSS) did not predict the 
variance in the rate of global or central atrophy, whereas the rate of central 
atrophy was significantly higher in younger patients. Twenty-eight patients with 
MS were followed for up to 14 years after the first onset of symptoms (Chard, 
2003), and lesion load in the first 5 years was more closely correlated with 
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disease-related brain atrophy at 14 years than were later changes in lesion load. 
Furthermore, in a cohort of patients with RR MS, lesion load (as derived from the 
average number of total and new gadolinium-enhanced lesions) decreased 
significantly with increasing patient age, independently of disease duration and 
relapse rate (Filippi, 2001). In line with the use of IFNβ in clinical practice, in a 
cross-sectional survey, it was found that patients assigned to treatment with IFNβ 
had a higher lesion load (adjusted mean of 1.6%; 95% CI 1.4 to 1.7) than those 
who had never received this drug because a watchful-waiting approach had been 
preferred (1.2%; 95% CI 1.0 to 1.5). 
 
Regional findings: GM 
Comparing our results to the only other work assessing cross-sectionally regional 
cortical GM loss in MS (Sailer, 2003), we are confirming a preferential fronto-
temporal cortical atrophy, although in that paper the involvement of precentral 
cortex was appreciated only for patient subgroups with longer disease duration, 
more severe disability and larger LL, and did not appear to be lateralized. 
Furthermore, in our data there is a lack of correlation between cortical GM loss 
and EDSS, disease duration or LL. 
 
Comparison of these results is however quite difficult for several reasons, 
including the use of different segmentation techniques (mono- vs. 
multiparametric), different measured entities (cortical thinning vs. local GM 
volume) and statistical analysis (ROI-based vs. voxel-based analysis when 
assessing correlations with clinical data), as well as different patient populations, 
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(mixed disease courses vs. pure RR MS), and further studies will be necessary to 
assess these differences. 
In particular, monoparametric and multiparametric segmentation techniques may  
have different accuracies, especially in presence of MS lesions (whose effect was 
however specifically ruled out in our case), while the assessment of the cortical 
thinning and of changes in local GM volume has different localization capabilities 
(in principle in favor of the cortical thickness assessment, which includes a 
smoothing limited to the cortical surface, while VBM implies a full 3D 
smoothing). 
Finally, the presence of progressive forms of MS in Sailer’s patient population, as 
well as differences in the clinical severity of the patient groups in the two studies 
(in our case only RR MS patients with EDSS ≤ 4.5 were selected, compared to 
patients with mixed disease course and EDSS ≤ 7 in the paper by Sailer et al., may 
have played a major role. 
Also a more recent study (Chen, 2004) assessing longitudinally the GM thickness 
in a mixed MS patient population (including both RR and secondary progressive 
disease course), has demonstrated a preferential correlation between the cortical 
thinning, especially in the precentral and parietal cortex, and the progression of 
disability over one year. 
Again, the differences in patient population (in our case only RR MS patients 
were included) and methodology may well explain the different findings as 
compared to our study, where a consequential cross-sectional finding of 
correlation between disability and atrophy was not present. 
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Among the deep GM structures, caudate nuclei also presented a highly significant 
bilateral volume loss, correlating with LL. 
Caudate nuclei border the lateral ventricles and may thus be prone to an indirect 
effect of ventricular enlargement due to spatial normalization inaccuracies, which 
may partly explain this finding. However, although the possibility that both 
mechanisms (true GM loss and normalization inaccuracies) are simultaneously 
present cannot be fully excluded, it should be reminded that caudate atrophy has 
been already detected in MS using manual parcellation (Bermel, 2003), although 
in that study no significant correlation with LL emerged. 
 
The lateralization of the GM loss, especially at the level of the motor area and 
transverse temporal cortex, does not seem related to the location of the plaques 
that presented a symmetric distribution (Fig. 18). 
To the best of our knowledge this is the first report of an asymmetric pattern of 
GM loss, with a preferential involvement of the left hemisphere in MS. 
Previously, lateralized functional changes have been described in MS, in 
relationship to cognitive disturbances, including left fronto-temporal metabolic 
and CBF reductions (Pozzilli, 1991; Pozzilli 1992) with a preferential correlation 
to deficits in verbal fluency and verbal memory, and alterations of the P600 
component of event related potentials in the left frontal and temporoparietal areas, 
in patients with memory disturbances (Sfagos, 2003). 
Although studies of MRI correlates of cognitive impairment in MS have reported 
in most cases a correlation with LL (Blinkenberg, 2000; Camp, 1999; Hohol, 
1997; Rao, 1989), this correlation appeared weak when were studied only RR-MS 
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patients (Fulton, 1999; Rovaris, 2002), a subgroup for which GM loss is emerging 
as a potential imaging correlate of cognitive impairment (Amato, 2004) . 
From this perspective regional GM loss may contribute to clarify the pathogenesis 
of specific deficits such as those reported in MS for the paced auditory serial 
addition test, which activates preferentially left fronto-parieto-temporal areas 
(Audoin, 2005) or for tests of verbal fluency, more frequently altered in RR MS 
compared to progressive forms of the disease (Huijbregts, 2004). Preferential left 
atrophy may also partly contribute to previously described correlations between 
NAA loss in the left hemisphere and  cognitive dysfunction in MS (Pan, 2001), a 
finding however not replicated in patients with more compromised verbal memory 
abilities with mixed disease course (Christodoulou, 2003). 
 
These information on the spatial distributions of aWM and GM loss have 
implications in the assessment of the mechanisms potentially underlying cortical 
atrophy in multiple sclerosis. 
Putative mechanisms for GM loss in MS include both Wallerian and retrograde 
neuroaxonal degeneration, which could partly contribute to the observed GM loss 
(Narayanan, 1997). 
However, it should be considered that if neuroaxonal degeneration was the main 
driving force of GM loss, visual cortex atrophy would also be expected due to the 
extensive involvement of optic pathways which occurs frequently in MS, while 
our data document a relative sparing of occipital GM, in agreement with previous 
results using different segmentation and analysis technique (Sailer, 2003). 
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Another mechanism for GM damage is the possible direct inflammatory damage 
(Kidd, 1999), which is expected due to the frequency of juxtacortical MS lesions 
and to the presence of MS lesions within GM. 
In particular, purely intracortical lesions represent up to 24% of the total LL 
(Kidd, 1999), and are particularly prominent in the frontal and the superior 
temporal lobe (Lumsden, 1970) and in the cingulate gyrus (Bo, 2003), with 
demyelination, axonal transection, dendritic transection, and apoptotic loss of 
neurons being detected at neuropathological studies (Peterson, 2001), although the 
mechanisms of tissue damage are still unclear, as cortical lesions show a different 
pattern of inflammation (fewer CD3-positive lymphocytes and CD68-positive 
microglia/macrophages than WM lesions) (Peterson, 2001). 
However, to confirm the correlation between intracortical lesions and GM loss, 
the lateralization of GM loss that we found should be coupled to a lateralization of 
intracortical lesions, a finding, although not specifically assessed, not reported by 
previous studies. 
Although visual assessment of the VBM results in subgroups of MS patients 
delineated an increased extent of the atrophic cortical areas with increasing LL, 
DD and EDSS, direct search for a correlation between these parameters and local 
GM volume did not show significant correlations for EDSS and DD while only 
limited cortical and subcortical clusters (caudates, motor cortex and hippocampus 
mainly) showed a correlation of atrophy with LL. 
This is not surprising as it is expected an increase in the extension of the affected 
GM regions with advancing pathology, rather than an increase in the degree of 
atrophy in the same regions. 
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The selective correlation with LL of caudate, motor cortex and hippocampal 
atrophy may suggest a different mechanism of involvement of these regions 
compared to other cortical GM, possibly related to the accumulation of damage 
with disease progression. In particular for basal ganglia, which are interconnected 
to a larger number of areas of the brain through basal ganglia-thalamo-cortical 
circuits (Alexander and Crutcher, 1990), an increased sensitivity to damage 
deriving from remote axonal transection through anterograde and retrograde 
neuronal degeneration can be hypothesized, as opposed to other areas of the brain 
where GM loss may result from other mechanisms. From this perspective is 
somewhat more surprising that the same relationship (between atrophy and LL) 
was not found also for thalami, a structure whose structural damage, correlated to 
distant normal-appearing WM axonal loss, as demonstrated in RR-MS using 
diffusion tensor and MR spectroscopy (Wylezinska, 2003) (see discussion on WM 
results). 
Finally, direct selective targeting and/or selective sensitivity of the affected 
regions to (as now unidentified) neurotoxic factors remains a viable hypothesis. 
 
Regional findings: WM 
Regional WM loss in MS has not been assessed at our knowledge. In previous 
studies assessing loss over pre-defined brain regions, decreases in both area and 
axonal density in corpus callosum (Evangelou, 2000) and in thalamic GM (Cifelli, 
2002) have been reported. 
Our VBM results on WM loss confirmed these findings showing a preferential 
location at the level of supratentorial periventricular regions, the involvement 
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being almost symmetrically distributed with a preferential involvement of the 
splenium of the corpus callosum. 
Involvement of thalami deserves a specific attention as this finding was to be 
expected as a results of GM loss. Conventional MRI segmentation is probably not 
sufficiently accurate in assessing the thalami, which are composed by GM nuclei 
interspersed in WM tracts and consequently difficult to segment appropriately, 
even when taking advantage of multiple MR information simultaneously by the 
use of a multiparametric approach as in this case. 
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CONCLUSIONS 
Our findings on quantification of GM and WM volumes in a large population of 
MS patients, confirmed both GM and global WM loss in patients as compared to 
normal subjects.  Moreover MRI data showed significant differences between 
patients with relapsing–remitting and secondary progressive forms of MS: 
secondary progressive patients have significantly more atrophy of both WM and 
GM than do relapsing–remitting patients and a significantly higher lesion load. 
Significant correlations among MRI parameters and between MRI and clinical 
data were found. Lesion load correlates to both WM and even more to GM 
atrophy; lesion load and WM and GM atrophy are significantly related to 
Expanded Disability Status Scale score and age at onset (suggesting that the 
younger the age at disease onset, the worse the lesion load and brain atrophy); and 
GM atrophy is the most significant MRI variable in determining the final 
disability. 
The two findings together confirm that a neurodegenerative phenomena should be 
considered. 
Moreover in RR MS the loss of GM appears preferentially located in the left 
fronto-temporal cortex and precuneus, in the anterior cingulate gyrus, and 
bilaterally in caudate nuclei, while WM analysis showed preferential loss at the 
level of supratentorial periventricular regions and thalami. 
The asymmetrical distribution of cortical atrophy is not explained by the volume 
of aWM or its symmetrical spatial distribution, and thus other mechanisms are 
probably involved in determining cortical GM loss, beside neuronal degeneration 
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from axonal transection in areas of the brain remote from GM, which probably 
plays a more direct role in deep GM atrophy. 
Future work needed to assess whether the differences in MS subtypes are 
correlated  to differences in regional brain tissue volumes. 
 85 
BIBLIOGRAPHY 
 
Adams, H.P., Koziol, J.A., 2000. Progressive cerebral atrophy in MS: a serial 
study using registered, volumetric MRI. Neurology 55, 1242-3. 
Alexander, G.E., Crutcher, M.D., 1990. Functional architecture of basal ganglia 
circuits: neural substrates of parallel processing. Trends Neurosci 13, 266-
71. 
Alfano, B., Brunetti, A., Covelli, E.M., Quarantelli, M., Panico, M.R., Ciarmiello, 
A., et al., 1997. Unsupervised, automated segmentation of the normal 
brain using a multispectral relaxometric magnetic resonance approach. 
Magn Reson Med 37, 84-93. 
Alfano, B., Brunetti, A., Larobina, M., Quarantelli, M., Tedeschi, E., Ciarmiello, 
A., et al., 2000. Automated segmentation and measurement of global white 
matter lesion volume in patients with multiple sclerosis. J Magn Reson 
Imaging 12, 799-807. 
Alfano, B., Quarantelli, M., Brunetti, A., Larobina, M., Covelli, E.M., Tedeschi, 
E., et al., 1998. Reproducibility of intracranial volume measurement by 
unsupervised multispectral brain segmentation. Magn Reson Med 39, 497-
9. 
Amato, M.P., Bartolozzi, M.L., Zipoli, V., Portaccio, E., Mortilla, M., Guidi, L., 
et al., 2004. Neocortical volume decrease in relapsing-remitting MS 
patients with mild cognitive impairment. Neurology 63, 89-93. 
Ashburner, J., Friston, K.J., 1999. Nonlinear spatial normalization using basis 
functions. Hum Brain Mapp 7, 254-66. 
Ashburner, J., Friston, K.J., 2000. Voxel-based morphometry--the methods. 
Neuroimage 11, 805-21. 
Ashburner, J., Neelin, P., Collins, D.L., Evans, A., Friston, K., 1997. 
Incorporating prior knowledge into image registration. Neuroimage 6, 
344-52. 
Atkins, M.S., Mackiewich, B.T., 1998. Fully automatic segmentation of the brain 
in MRI. IEEE Trans Med Imaging 17, 98-107. 
 86 
Audoin, B., Ibarrola, D., Au Duong, M.V., Pelletier, J., Confort-Gouny, S., 
Malikova, I., et al., 2005. Functional MRI study of PASAT in normal 
subjects. Magma 18, 96-102. 
Bakker, C.J., de Graaf, C.N., van Dijk, P., 1984. Derivation of quantitative 
information in NMR imaging: a phantom study. Phys Med Biol 29, 1511-
25. 
Bermel, R.A., Innus, M.D., Tjoa, C.W., Bakshi, R., 2003. Selective caudate 
atrophy in multiple sclerosis: a 3D MRI parcellation study. Neuroreport 
14, 335-9. 
Blinkenberg, M., Rune, K., Jensen, C.V., Ravnborg, M., Kyllingsbaek, S., Holm, 
S., et al., 2000. Cortical cerebral metabolism correlates with MRI lesion 
load and cognitive dysfunction in MS. Neurology 54, 558-64. 
Bo, L., Vedeler, C.A., Nyland, H.I., Trapp, B.D., Mork, S.J., 2003. Subpial 
demyelination in the cerebral cortex of multiple sclerosis patients. J 
Neuropathol Exp Neurol 62, 723-32. 
Bozzali, M., Cercignani, M., Sormani, M.P., Comi, G., Filippi, M., 2002. 
Quantification of brain gray matter damage in different MS phenotypes by 
use of diffusion tensor MR imaging. AJNR Am J Neuroradiol 23, 985-8. 
Brummer, m., Mersereau, r., Eisner, r., Lewine, r., 1993. Automatic detection of 
brain contours in MRI data sets. IEEE Transactions on Medical imaging 
12, 153-166. 
Camp, S.J., Stevenson, V.L., Thompson, A.J., Miller, D.H., Borras, C., 
Auriacombe, S., et al., 1999. Cognitive function in primary progressive 
and transitional progressive multiple sclerosis: a controlled study with 
MRI correlates. Brain 122 ( Pt 7), 1341-8. 
Chakraborty, A., Staib, L., Duncan, J.S. An integrated approach to boundary 
finding in medical images. IEEE Workshop on Biomedical Image 
Analysis. Los Alamos, CA, 1994: 13-22. 
Chard, D.T., Brex, P.A., Ciccarelli, O., Griffin, C.M., Parker, G.J., Dalton, C., et 
al., 2003. The longitudinal relation between brain lesion load and atrophy 
in multiple sclerosis: a 14 year follow up study. J Neurol Neurosurg 
Psychiatry 74, 1551-4. 
 87 
Chard, D.T., Griffin, C.M., Parker, G.J., Kapoor, R., Thompson, A.J., Miller, 
D.H., 2002. Brain atrophy in clinically early relapsing-remitting multiple 
sclerosis. Brain 125, 327-37. 
Chen, J.T., Narayanan, S., Collins, D.L., Smith, S.M., Matthews, P.M., Arnold, 
D.L., 2004. Relating neocortical pathology to disability progression in 
multiple sclerosis using MRI. Neuroimage 23, 1168-75. 
Christodoulou, C., Krupp, L.B., Liang, Z., Huang, W., Melville, P., Roque, C., et 
al., 2003. Cognitive performance and MR markers of cerebral injury in 
cognitively impaired MS patients. Neurology 60, 1793-8. 
Cifelli, A., Arridge, M., Jezzard, P., Esiri, M.M., Palace, J., Matthews, P.M., 
2002. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52, 
650-3. 
Dalton, C.M., Chard, D.T., Davies, G.R., Miszkiel, K.A., Altmann, D.R., 
Fernando, K., et al., 2004. Early development of multiple sclerosis is 
associated with progressive grey matter atrophy in patients presenting with 
clinically isolated syndromes. Brain 127, 1101-7. 
Davie, C.A., Barker, G.J., Webb, S., Tofts, P.S., Thompson, A.J., Harding, A.E., 
et al., 1995. Persistent functional deficit in multiple sclerosis and 
autosomal dominant cerebellar ataxia is associated with axon loss. Brain 
118 ( Pt 6), 1583-92. 
Davie, C.A., Hawkins, C.P., Barker, G.J., Brennan, A., Tofts, P.S., Miller, D.H., 
et al., 1994. Serial proton magnetic resonance spectroscopy in acute 
multiple sclerosis lesions. Brain 117 ( Pt 1), 49-58. 
Dawant, B.M., Hartmann, S.L., Thirion, J.P., Maes, F., Vandermeulen, D., 
Demaerel, P., 1999. Automatic 3-D segmentation of internal structures of 
the head in MR images using a combination of similarity and free-form 
transformations: Part I, Methodology and validation on normal subjects. 
IEEE Trans Med Imaging 18, 909-16. 
De Stefano, N., Matthews, P.M., Filippi, M., Agosta, F., De Luca, M., Bartolozzi, 
M.L., et al., 2003. Evidence of early cortical atrophy in MS: relevance to 
white matter changes and disability. Neurology 60, 1157-62. 
 88 
De Stefano, N., Narayanan, S., Francis, G.S., Arnaoutelis, R., Tartaglia, M.C., 
Antel, J.P., et al., 2001. Evidence of axonal damage in the early stages of 
multiple sclerosis and its relevance to disability. Arch Neurol 58, 65-70. 
Edwards, S.G., Gong, Q.Y., Liu, C., Zvartau, M.E., Jaspan, T., Roberts, N., et al., 
1999. Infratentorial atrophy on magnetic resonance imaging and disability 
in multiple sclerosis. Brain 122 ( Pt 2), 291-301. 
Evangelou, N., Konz, D., Esiri, M.M., Smith, S., Palace, J., Matthews, P.M., 
2000. Regional axonal loss in the corpus callosum correlates with cerebral 
white matter lesion volume and distribution in multiple sclerosis. Brain 
123 ( Pt 9), 1845-9. 
Farmer, M. Segmentation of Medical Images using Fuzzy CMeans Clustering, 
Oriented Edges, and a Recurrent Competitive Field Neural Network. 
University of Tennessee at Chattanooga, Department of Computer 
Science., 1996. 
Ferguson, B., Matyszak, M.K., Esiri, M.M., Perry, V.H., 1997. Axonal damage in 
acute multiple sclerosis lesions. Brain 120 ( Pt 3), 393-9. 
Filippi, M., Rocca, M.A., 2003. Disturbed function and plasticity in multiple 
sclerosis as gleaned from functional magnetic resonance imaging. Curr 
Opin Neurol 16, 275-82. 
Filippi, M., Wolinsky, J.S., Sormani, M.P., Comi, G., 2001. Enhancement 
frequency decreases with increasing age in relapsing-remitting multiple 
sclerosis. Neurology 56, 422-3. 
Friston, K.J., Holmes, A.P., Poline, J.B., Grasby, P.J., Williams, S.C., 
Frackowiak, R.S., et al., 1995. Analysis of fMRI time-series revisited. 
Neuroimage 2, 45-53. 
Fulton, J.C., Grossman, R.I., Udupa, J., Mannon, L.J., Grossman, M., Wei, L., et 
al., 1999. MR lesion load and cognitive function in patients with relapsing-
remitting multiple sclerosis. AJNR Am J Neuroradiol 20, 1951-5. 
Ge, Y., Grossman, R.I., Udupa, J.K., Babb, J.S., Nyul, L.G., Kolson, D.L., 2001. 
Brain atrophy in relapsing-remitting multiple sclerosis: fractional 
volumetric analysis of gray matter and white matter. Radiology 220, 606-
10. 
 89 
Good, C.D., Johnsrude, I., Ashburner, J., Henson, R.N., Friston, K.J., Frackowiak, 
R.S., 2001a. Cerebral asymmetry and the effects of sex and handedness on 
brain structure: a voxel-based morphometric analysis of 465 normal adult 
human brains. Neuroimage 14, 685-700. 
Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N., Friston, K.J., 
Frackowiak, R.S., 2001b. A voxel-based morphometric study of ageing in 
465 normal adult human brains. Neuroimage 14, 21-36. 
Hartmann, S.L., Parks, M.H., Martin, P.R., Dawant, B.M., 1999. Automatic 3-D 
segmentation of internal structures of the head in MR images using a 
combination of similarity and free-form transformations: Part II, validation 
on severely atrophied brains. IEEE Trans Med Imaging 18, 917-26. 
Hohol, M.J., Guttmann, C.R., Orav, J., Mackin, G.A., Kikinis, R., Khoury, S.J., et 
al., 1997. Serial neuropsychological assessment and magnetic resonance 
imaging analysis in multiple sclerosis. Arch Neurol 54, 1018-25. 
Hojjatoleslami, S.A., Kruggel, F., 2001. Segmentation of large brain lesions. 
IEEE Trans Med Imaging 20, 666-9. 
Holden, M., Steen, E., Lundervold, A., 1995. Segmentation and visualization of 
brain lesions in multispectral magnetic resonance images. Comput Med 
Imaging Graph 19, 171-83. 
Huijbregts, S.C., Kalkers, N.F., de Sonneville, L.M., de Groot, V., Reuling, I.E., 
Polman, C.H., 2004. Differences in cognitive impairment of relapsing 
remitting, secondary, and primary progressive MS. Neurology 63, 335-9. 
Jackson, E.F., Narayana, P.A., Wolinsky, J.S., Doyle, T.J., 1993. Accuracy and 
reproducibility in volumetric analysis of multiple sclerosis lesions. J 
Comput Assist Tomogr 17, 200-5. 
Johnston, b., Atkins, M.S., Mackiewich, C., M, A., 1996. Segmentation of 
multiple sclerosis lesions in intensity corrected multispectral MRI. IEEE 
Transactions on Medical Imaging 15, 154-169. 
Kalkers, N.F., Ameziane, N., Bot, J.C., Minneboo, A., Polman, C.H., Barkhof, F., 
2002. Longitudinal brain volume measurement in multiple sclerosis: rate 
of brain atrophy is independent of the disease subtype. Arch Neurol 59, 
1572-6. 
 90 
Kamber, M., shingal, r., collins, d., Francis, G.S., evans, A., 1995. Model-based 3-
D segmentation of multiple sclerosis lesions in magnetic resonance brain 
images. IEEE Transactions in Medical Imaging 14, 442-453. 
Kapur, T. Segmentation of brain tissue from magnetic resonance images.: MIT AI 
Lab, 1995. 
Karas, G.B., Burton, E.J., Rombouts, S.A., van Schijndel, R.A., O'Brien, J.T., 
Scheltens, P., et al., 2003. A comprehensive study of gray matter loss in 
patients with Alzheimer's disease using optimized voxel-based 
morphometry. Neuroimage 18, 895-907. 
Kaus, M.R., Pekar, V., Lorenz, C., Truyen, R., Lobregt, S., Weese, J., 2003. 
Automated 3-D PDM construction from segmented images using 
deformable models. IEEE Trans Med Imaging 22, 1005-13. 
Kidd, D., Barkhof, F., McConnell, R., Algra, P.R., Allen, I.V., Revesz, T., 1999. 
Cortical lesions in multiple sclerosis. Brain 122 ( Pt 1), 17-26. 
Kurtzke, J.F., 1983. Rating neurologic impairment in multiple sclerosis: an 
expanded disability status scale (EDSS). Neurology 33, 1444-52. 
Laidlaw, D.H., Fleischer, K.W., Barr, A.H., 1998. Partial-volume Bayesian 
classification of material mixtures in MR volume data using voxel 
histograms. IEEE Trans Med Imaging 17, 74-86. 
Letteboer, M.M., Olsen, O.F., Dam, E.B., Willems, P.W., Viergever, M.A., 
Niessen, W.J., 2004. Segmentation of tumors in magnetic resonance brain 
images using an interactive multiscale watershed algorithm. Acad Radiol 
11, 1125-38. 
Liu, C., Edwards, S., Gong, Q., Roberts, N., Blumhardt, L.D., 1999. Three 
dimensional MRI estimates of brain and spinal cord atrophy in multiple 
sclerosis. J Neurol Neurosurg Psychiatry 66, 323-30. 
Losseff, N.A., Wang, L., Lai, H.M., Yoo, D.S., Gawne-Cain, M.L., McDonald, 
W.I., et al., 1996. Progressive cerebral atrophy in multiple sclerosis. A 
serial MRI study. Brain 119 ( Pt 6), 2009-19. 
Lublin, F.D., Reingold, S.C., 1996. Defining the clinical course of multiple 
sclerosis: results of an international survey. National Multiple Sclerosis 
 91 
Society (USA) Advisory Committee on Clinical Trials of New Agents in 
Multiple Sclerosis. Neurology 46, 907-11. 
Luders, E., Gaser, C., Jancke, L., Schlaug, G., 2004. A voxel-based approach to 
gray matter asymmetries. Neuroimage 22, 656-64. 
Lumsden, C. The neuropathology of multiple sclerosis. In: Vinken PJ BG, editor. 
Handbook of clinical neurology. Vol 9. Amsterdam: North-Holland, 1970: 
217-309. 
McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, 
F.D., et al., 2001. Recommended diagnostic criteria for multiple sclerosis: 
guidelines from the International Panel on the diagnosis of multiple 
sclerosis. Ann Neurol 50, 121-7. 
Miller, D.H., Barkhof, F., Frank, J.A., Parker, G.J., Thompson, A.J., 2002. 
Measurement of atrophy in multiple sclerosis: pathological basis, 
methodological aspects and clinical relevance. Brain 125, 1676-95. 
Mitchell, J.R., Karlik, S.J., Lee, D.H., Fenster, A., 1994. Computer-assisted 
identification and quantification of multiple sclerosis lesions in MR 
imaging volumes in the brain. J Magn Reson Imaging 4, 197-208. 
Mohamed, F.B., Vinitski, S., Faro, S.H., Gonzalez, C.F., Mack, J., Iwanaga, T., 
1999. Optimization of tissue segmentation of brain MR images based on 
multispectral 3D feature maps. Magn Reson Imaging 17, 403-9. 
Narayanan, S., Fu, L., Pioro, E., De Stefano, N., Collins, D.L., Francis, G.S., et 
al., 1997. Imaging of axonal damage in multiple sclerosis: spatial 
distribution of magnetic resonance imaging lesions. Ann Neurol 41, 385-
91. 
Pan, J.W., Krupp, L.B., Elkins, L.E., Coyle, P.K., 2001. Cognitive dysfunction 
lateralizes with NAA in multiple sclerosis. Appl Neuropsychol 8, 155-60. 
Pannizzo, F., Stallmeyer, M.J., Friedman, J., Jennis, R.J., Zabriskie, J., Plank, C., 
et al., 1992. Quantitative MRI studies for assessment of multiple sclerosis. 
Magn Reson Med 24, 90-9. 
Pelletier, D., Garrison, K., Henry, R., 2004. Measurement of whole-brain atrophy 
in multiple sclerosis. J Neuroimaging 14, 11S-19S. 
 92 
Peterson, J.W., Bo, L., Mork, S., Chang, A., Trapp, B.D., 2001. Transected 
neurites, apoptotic neurons, and reduced inflammation in cortical multiple 
sclerosis lesions. Ann Neurol 50, 389-400. 
Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, 
G.C., et al., 1983. New diagnostic criteria for multiple sclerosis: guidelines 
for research protocols. Ann Neurol 13, 227-31. 
Quarantelli, M., Ciarmiello, A., Morra, V.B., Orefice, G., Larobina, M., Lanzillo, 
R., et al., 2003. Brain tissue volume changes in relapsing-remitting 
multiple sclerosis: correlation with lesion load. Neuroimage 18, 360-6. 
Ranganath, s., 1995. Contour extraction from cardiac MRI studies using snake. 
IEEE Transactions on Medical imaging 14, 328-338. 
Rao, S.M., Leo, G.J., Haughton, V.M., St Aubin-Faubert, P., Bernardin, L., 1989. 
Correlation of magnetic resonance imaging with neuropsychological 
testing in multiple sclerosis. Neurology 39, 161-6. 
Rooney, W.D., Goodkin, D.E., Schuff, N., Meyerhoff, D.J., Norman, D., Weiner, 
M.W., 1997. 1H MRSI of normal appearing white matter in multiple 
sclerosis. Mult Scler 3, 231-7. 
Rovaris, M., Iannucci, G., Falautano, M., Possa, F., Martinelli, V., Comi, G., et 
al., 2002. Cognitive dysfunction in patients with mildly disabling 
relapsing-remitting multiple sclerosis: an exploratory study with diffusion 
tensor MR imaging. J Neurol Sci 195, 103-9. 
Rudick, R.A., Fisher, E., Lee, J.C., Simon, J., Jacobs, L., 1999. Use of the brain 
parenchymal fraction to measure whole brain atrophy in relapsing-
remitting MS. Multiple Sclerosis Collaborative Research Group. 
Neurology 53, 1698-704. 
Sailer, M., Fischl, B., Salat, D., Tempelmann, C., Schonfeld, M.A., Busa, E., et 
al., 2003. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 
126, 1734-44. 
Sfagos, C., Papageorgiou, C.C., Kosma, K.K., Kodopadelis, E., Uzunoglu, N.K., 
Vassilopoulos, D., et al., 2003. Working memory deficits in multiple 
sclerosis: a controlled study with auditory P600 correlates. J Neurol 
Neurosurg Psychiatry 74, 1231-5. 
 93 
Simon, J.H., Jacobs, L.D., Campion, M.K., Rudick, R.A., Cookfair, D.L., 
Herndon, R.M., et al., 1999. A longitudinal study of brain atrophy in 
relapsing multiple sclerosis. The Multiple Sclerosis Collaborative 
Research Group (MSCRG). Neurology 53, 139-48. 
Suzuki, H., Toriwaki, J., 1991. Automatic segmentation of head MRI images by 
knowledge guided thresholding. Comput Med Imaging Graph 15, 233-40. 
Talairach, J., Tournoux, P. Co-planar Stereotaxic Atlas of the Human Brain - 3-
Dimensional Proportional system: An Approach to cerebral imaging. New 
york: Thieme, 1988. 
Trapp, B.D., Peterson, J., Ransohoff, R.M., Rudick, R., Mork, S., Bo, L., 1998. 
Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338, 
278-85. 
Udupa, J.K., Wei, L., Samarasekera, S., Miki, Y., van Buchem, M.A., Grossman, 
R.I., 1997. Multiple sclerosis lesion quantification using fuzzy-
connectedness principles. IEEE Trans Med Imaging 16, 598-609. 
Vaillant, M., Davatzikos, C., 1997. Finding parametric representations of the 
cortical sulci using an active contour model. Med Image Anal 1, 295-315. 
Van Leemput, K., Maes, F., Vandermeulen, D., Colchester, A., Suetens, P., 2001. 
Automated segmentation of multiple sclerosis lesions by model outlier 
detection. IEEE Trans Med Imaging 20, 677-88. 
Woods, R.P., Grafton, S.T., Watson, J.D., Sicotte, N.L., Mazziotta, J.C., 1998. 
Automated image registration: II. Intersubject validation of linear and 
nonlinear models. J Comput Assist Tomogr 22, 153-65. 
Wylezinska, M., Cifelli, A., Jezzard, P., Palace, J., Alecci, M., Matthews, P.M., 
2003. Thalamic neurodegeneration in relapsing-remitting multiple 
sclerosis. Neurology 60, 1949-54. 
Zijdenbos, A.P., Dawant, b., Margolin, r., Palmer, a., 1994. Morphometric 
analysis of white matter lesions in MR images: method and validation. 
IEEE Transactions on Medical Imaging 13, 716-724. 
 
